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Chapter I 
Abdominal Aortic Aneurysm  
 
1.1 Background  
The term aneurysm originates from the Greek word Ανεύρυσμα (Aneurysma), 
meaning a widening. An aneurysm is defined as a local, permanent dilatation of an 
artery at least 1.5 times its normal diameter (Figure 1.1). Any artery can become 
aneurysmal yet the infrarenal segment of the abdominal aorta is the most common 
site for development of Abdominal Aortic Aneurysms (AAAs). 
 
 
Figure 1.1 Anatomy of Abdominal Aortic Aneurysm 
 
The prevalence of AAA is growing along with population age and according to 
different studies AAA rupture is the 13th most common cause of death in the United 
States (1) causing an estimated 15.000 deaths per year.  
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The incidence of AAA is 2-4 per cent in the adult population and it is growing 
with increase in the average population age. The risk of AAA in white males is 
elevated as compared to black males who have a hazard ratio of 0.57 compared to 
white men (2). In women the incidence of AAA is much lower, mostly likely due to 
hormonal differences.  
AAA’s are asymptomatic and are rarely detected until rupture. The incidence 
of asymptomatic AAA’s appear to be 0.8% at age 50 and increase to 6% at age 65 in 
males (3). Rupture is defined as extravasion of blood or hematoma outside the AAA. 
(4). One third of untreated AAA’s will rupture. Ruptured AAA’s (rAAA) are responsible 
for 1.3% of all deaths among males between the ages of 65– 85 years. (5,6). 
Ruptured AAA’s require emergency surgery and have an associated mortality rate of 
65–85% half of which occur prior to surgery. It is more preferable to perform elective 
surgery on AAA’s before they rupture. The mortality rate for elective AAA repair is 
0%-9%, a rate significantly lower than emergency repair surgery. (6-12). 
AAA’s are mainly asymptomatic; therefore screening is required for diagnosis. 
Once diagnosed, the aneurysm size and growth can be kept under surveillance to 
assess the risk of rupture. An AAA of 5.5 - 6cm is considered as a risk of rupture. 
Once it is considered as a risk, elective surgery is recommended. Previous studies 
have shown that screening for AAA’s is cost effective and can reduce the mortality 
rate. (6, 7, 13 - 16). 
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1.2 Historical perspectives 
Aneurysms might have been known in ancient Egypt, although Shushruta, a 
surgeon who lived in India, probably made the first written record sometime between 
800 and 600 BC, in the treatise Sira Granthi, ‘Tumours of the vessels’ (Prakash 
1978). Rufus of Ephesus (110-180 AD) advised treating an aneurysm with digital 
compression, torsion or ligature of the artery. Galen of Pergamon (129-201AD) 
described two types of aneurysms, one being a dilatation of the artery and the other 
a result of injury to an artery. 
In the early Byzantine era (Byzantine Empire 395-1453 AD) Oribasios of 
Pergamon (325-403 AD) was the first to discuss operative indications, warning 
against hasty surgery on large aneurysms, especially those in the armpit groin and 
neck. He also referred to Antyllos who had earlier described complete exposure and 
ligation of non-traumatic aneurysms. At this time in history, the Greeks called an area 
being dilated; ‘aneurysma’ 
The Belgian anatomist and physician Vesalius (1514-1564) was one of the 
first to describe an AAA. The treatment of aneurismal disease consisted primarily of 
ligation during the 18th and 19th century. Several innovative techniques such as 
external compression, wiring and electrocoagulation and cellophane wrapping were 
tried in the late 19th and first half of the 20th century. 
The first successful reconstructive AAA repair was performed in 1951 by 
Freeman and Leeds (Freeman, 1951) and in the following years, the first repair of a 
rAAA was performed (Bahnson, 1953). Early on, freeze-dried homograft was used to 
replace the aorta (Dubost, 1952), which subsequently was replaced by more durable 
synthetic prostheses such as Vinyon-N cloth (Voorhees, 1952) and knitted Dacron 
(De Bakey, 1958). The innovative technique of endovascular aneurysm repair was 
first described by Volodos in the Russian medical literature (Volodos, 1986), and was 
later disseminated in clinical practice by Parodi (Parodi, 1991). 
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1.3 Risk Factors for AAA development 
Abdominal Aortic aneurysm is a complex vascular condition with no one 
specific cause for its development. Risk factors for AAA formation include male sex, 
age, smoking, family history as well as atherosclerosis (3, 17). 
 
1.3.1 Gender: 
Male sex is the most predominant risk factor. AAA’s occur up to 5 times more 
in men than in women (3). With the incidence of AAA in women thought to be 0.7% 
compared to that of men, which is 3.9% (18, 19). However, the growth rate of AAA’s 
is significantly higher in females than in males (20, 21).Women have smaller 
anatomies compared to men therefore the risk of rupture in females is at a smaller 
AAA size compared to males (6,16,22-24). 
AAA’s in males are reported at 65 years and older; where as AAA’s in women 
occur in a later age group (75-80 years) (22). When women are diagnosed with AAA 
they usually have other co morbid conditions, making treatment of their AAA 
complicated. The risk of AAA in females compared to males appears to be similar to 
their risk for cardiovascular disease. Females are protected from such disease in 
their middle ages due to the high level of oestrogen in their system pre-menopause. 
A lab based study documented a decrease in AAA formation in male rats when they 
were treated with oestrogen, thus like other cardiovascular diseases, oestrogen may 
protect females from AAA formation until later in life (18) 
Astrand et al reported that stress on the male abdominal aortic wall increases 
with age and its response to compensatory thickening is insufficient, unlike that of the 
female abdominal aorta (25) 
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1.3.2 Age: 
The incidence of AAA increases with age from 0.8% in males at the age of 50 
years to 6% of those aged 65 years (3). The risk of AAA formation and rupture 
increases with age, with the incidence peaking at 65-70 years in males (3, 26, 27), 
whereas in women it is at 70-80years (19,21). AAA usually presents in women who 
are at an older stage of life compared to men (21, 24) 
 
1.3.3 Smoking: 
Smoking appears to be one of the strongest independent risk factors for AAA 
formation and growth (11, 12, 28,  29). Current smoking and duration of smoking are 
the most prevalent (12, 11, 30, 31). 
Life- time male smokers are 2.5 times more likely to present with an AAA than 
non-smoking males (15). Patients who have been previous smokers have reduced 
risk of death compared to current smokers (15). Previous smoking still poses a risk, 
but at a lower incidence of 1.5 times that of non-smokers (3). A study by Lee et al of 
current and recent ex-smokers the likelihood of AAA was 3 times greater than ex-
smokers of 5 years and more, than those who never smoked (28). Smoking has also 
been proven to be the biggest risk predictor for AAA in females (19). Studies have 
shown that smoking increases growth rates of AAA’s by 15-20% and therefore 
increasing the risk of rupture (6, 28, 32). 
The link between smoking and its strong association with AAA formation and 
growth appears unknown; however some studies suggest serum cotinine, a nicotine 
metabolite increases growth rate of AAA’s (30). It is also thought that some 
components of smoking may inhibit the active site of 1 –antitrypsin, leading to the 
degradation of elastin in the aortic wall by proteolytic enzymes (28, 30). 
Receptors that can bind nicotine are not only present on neurons but also on 
lymphocytes and macrophages (53). Neutrophils exposed to nicotine increase their 
expression of elastase (54). Nicotine also activates matrix metalloproteinase (MMP2) 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:26:56 EEST - 137.108.70.13
 6 
 
expression by smooth muscle cells in the vessel wall, enhancing AAA formation in 
animals in vivo. Studies in vitro indicate that tobacco smoke extracts cause death of 
human and animal smooth muscle cells, arterial and pulmonary endothelial cells,  and 
human monocyte/macrophages (55, 56, 57). 
The association of smoking and AAA formation and progression is much more 
pronounced than the association of smoking with coronary artery disease (CAD) (33). 
Long term smokers have a higher possibility of death from AAA’s than CAD. This 
suggests that AAA formation is not independantly caused by the atherosclerotic 
process (28, 30, 33). 
 
1.3.4 Atherosclerosis: 
Atherosclerosis is associated with damage to the endothelial lining and lipid 
deposits in the tunica media. Increased lipid levels in the blood initiates the formation 
of atherosclerosis. 
Atherosclerosis formation occurs with breakdown of the endothelial wall, 
promoting aggregation of platelets and also attracting phagocytes. Cholesterol and 
triglycerides collect at the injury site of the inner layer of the arterial wall. 
Macrophages arrive at the site due to the inflammatory process. Contact with 
platelets, lipids and other components of blood stimulate smooth muscle cells and 
collagen fibres in the arterial wall to proliferate abnormally. This occurs due to low 
levels of apolipoprotein- E (ApoE), which transports lipid in the blood and are quickly 
absorbed by body tissues or by high levels of low density lipoprotein which is slowly 
absorbed by the body. In response to this there is a build up of lipids and formation of 
atherosclerosis which causes a narrowing in the arterial wall and disturbance to the 
blood flow (34, 35).  
The inflammatory process of atherosclerosis is linked with the AAA formation, 
enlargement and rupture cycle (36-38). One study implicates the inflammatory 
response as a potential cause of aneurysm rupture (39). Matrix metallopeptidase 9 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:26:56 EEST - 137.108.70.13
 7 
 
(MMP9) is an enzyme when secreted presents a pathway for collagen degradation, 
AAA expansion and rupture. (40) However, this does not prove that atherosclerosis 
and an inflammatory response is a direct cause of AAA. A recent study examined the 
diabetic association of AAA and reports atherosclerosis as an associated feature and 
not a causative factor (41). (Figure 1.2) 
 
 
Figure 1.2 The inflammatory process involved in the formation of 
atherosclerosis  
 
1.3.5 Hypertension  
Hypertension (HTN) has been shown to pose a risk of AAA formation (28). 
There are conflicting studies which argue that HTN is risk of rupture rather than 
formation and growth of an AAA. While other studies have reported that there is no 
relationship between HTN and formation of AAA or increased expansion rates of 
existing AAA’s (3, 12, 32). 
HTN has been shown to be associated with AAA rupture due to its 
haemodynamic stress effect and its involvement in the up regulation of transcription 
factors (42, 25). The haemodynamic burden on the aortic wall depends on the mean 
blood pressure. An elevated burden is constantly putting pressure on the ever 
weakening aneurismal section causing the AAA to enlarge (15). In large and ruptured 
AAA’s the wall stress at maximal systolic blood pressure is considerably higher than 
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in small AAA’s (6, 25, 39, 43) which shows the association between HTN and 
rupture.  
 
1.3.6 The role of high cholesterol: 
Elevated LDL cholesterol, total cholesterol and triglycerides have been 
recorded in patients with AAA (12, 28). Studies have shown that cholesterol alone 
does not cause aortic enlargement (44, 45, 46). Significant association of plasma 
LDL and small aortic aneurysms has been shown (47). One study has shown that 
small LDL size is an independent risk factor for AAA (48). However, Golledge et al 
claims there is no association between LDL and AAA, but there is consistent 
association between low HDL and small AAA (49). HDL has anti-inflammatory and 
antioxidant properties and a low HDL level reduces its preventive properties and 
therefore may lead to inflammation of the abdominal aorta (49). 
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1.3.7 Relationship of Diabetes Mellitus and AAA: 
Most studies have shown the inverse effect of Diabetes Mellitus (DM) on AAA 
formation and growth (19, 32, 41, 50). 
One study has shown the association of the circulating marker of the glycation 
pathway, carboxymethyllysine (CML) and discovered levels of CML to be lower in 
patients with diabetes and AAA compared to patients with AAA and no diabetes (51). 
Another study suggests that hyperglycemia inhibits metalloprotinases (MMP) 
production, and therefore inhibiting MMP activity which is essential in AAA 
progression (52). 
This is one explanation of the negative relationship of DM and AAA formation. 
(Figure 1.3) 
 
 
Figure 1.3 Effect of diabetes on AAA 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:26:56 EEST - 137.108.70.13
 10 
 
The above diagram shows the inverse effect of diabetes in AAA expansion. In 
hyperinsulinaemiam, decreased fibrinolysis leads to decreased mural thrombus 
formation which accumulates in an AAA. The less mural thrombus present prevents 
the AAA from expanding further. 
Hyperglycaemia causes that arterial wall to stiffen due to an increase in 
matrix, protein crosslinking and vainculin positive focal adhesions. Due to this 
increased wall stiffness the aneurysm is unable to expand further. 
The therapeutic agents given to diabetes sufferers, decrease inflammation, 
MMP levels and blood pressure. All of which are heavily involved in the formation 
and expansion of an AAA. 
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1.4 NATURAL HISTORY: GROWTH AND RUPTURE  
 
1.4.1 Growth  
It is generally assumed that the natural history of an AAA is continuous 
growth and eventual rupture. Growth and associated risk factors have been 
assessed in patients with small aneurysms or patients unfit for surgery. Annual AAA 
expansion rate is reported to be approximately 0.2‐0.3 cm (9, 20, 32, 54‐58) but there 
are substantial individual variations. In the United Kingdom Small Aneurysm Trial 
(UKSAT) and the Aneurysm Detection and Management (ADAM) trial the median 
annual growth rate was 0.3 cm in AAAs 4.0‐5.5 cm.9,58 Aneurysm with a diameter f 
3.0‐3.9 cm, followed outside the ADAM trial, had a median annual growth rate of 0.1 
cm/year.(59) 
Several conditions and diseases influence AAA growth. Large initial aneurysm 
diameter (9, 32, 54, 60), smoking (32, 55, 61)  and age (61, 62,) have been reported 
to be risk factors for AAA growth. Presence of diabetes is associated with slower 
AAA growth.(9,32) The association between AAA growth and different manifestations 
of cardiovascular disease, such as suboptimal lipid profile, hypertension and low 
ankle/brachial pressure index are, however, less clear (32, 45, 55). 
 Female sex has been reported to be an independent risk factor for an 
increasing AAA growth rate (20, 54, 57) although contradicted by others (32, 55, 56). 
In two of the studies showing no association, few women were included. 
Nevertheless, this is an important subject of study, particularly when taking into 
account the reported higher rupture risk in female AAA patients.  
 Statin use and angiotensin converting enzyme inhibitor therapy have been 
reported to be associated with decreased AAA growth and lower rupture risk (57, 63). 
However, patients taking angiotensin converting enzyme inhibitors were recently 
reported to have faster aneurysm growth, in conflict with previous results (64). 
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Whether or not statin or angiotensin converting enzyme inhibitor therapy should be 
initiated to inhibit aneurysm expansion remains to be clarified.  
 
1.4.2 Rupture  
Aneurysm diameter is the currently used clinically predictor of rupture. 
Elective repair of AAA can prevent rupture but is associated with a non-negligible risk 
of mortality. In the large trials comparing patients with AAAs 4.0‐5.5 cm kept under 
surveillance with prophylactic surgery, the UKSAT and the ADAM trial, elective repair 
of small aneurysms was not associated with superior survival (9, 65). These trials 
have had a strong influence on management of AAA patients in clinical practice.  
The annual rupture rates for the surveillance groups were 0.6% in the ADAM 
trial and 1.0% in the UKSAT. In a study investigating the rupture rate of AAA of at 
least 5.5 cm in patients not planned for aortic intervention due to medical 
contraindications or patient refusal, the estimated yearly risk of rupture was markedly 
higher, 10.2% in patients with AAA ≥6.0 cm and 32.5% in patients it a diameter of 7.0 
cm or more (66).  Due to the study design it is difficult to generalize these results to 
an average AAA population. 
 Follow up of AAA patients aims to assess the risk of rupture versus risks 
associated with intervention. In a follow up of the UKSAT study population and an 
associated study of patients monitored for aneurysm growth, including totally 2257 
patients of whom 21% were women, risk factors for rupture were investigated (6). 
Low forced expiratory volume in the first second (FEV1) and current smoking were 
associated with the risk of rupture. A higher mean arterial pressure (MAP) increased 
the risk slightly, adjusted hazard ratio was 1.02 (95% Confidence Interval (CI) 
1.00‐1.02 per mm Hg). A threefold increased risk of rupture was recorded in women 
after adjustment for initial aneurysm diameter, age and body size (6). The risk of 
aneurysm rupture was four times higher in women than men in the long‐term follow 
up of the UKSAT (65) In a Finnish study of 221 patients (22% women) who died of 
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ruptured AAA, a higher proportion of women were found among patients with 
ruptured AAA smaller than 5,5 cm in diameter (67). In a study of 476 AAA patients 
(21% women) considered unfit for surgery, a four time higher risk for women with 
aneurysms 5.0‐5.9 cm compared to men was recorded (24). Furthermore, a study 
from the United Kingdom of 210 subjects (22% women) showed that women with 
AAA have a shorter time to rupture compared to men with the same aneurysm 
diameter (68).  In a report from the United States, based on the Nationwide Inpatient 
Sample, a higher percentage of women with AAA presented with rupture compared 
to men (69). It is clear that women have a more unfavorable aneurysm disease 
compared to men. The contributing causes to the increased risk of rupture among 
female AAA patients are not fully understood and further studies within the area are 
needed. 
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Chapter II  
Methods of Diagnosis of AAA: 
 
2. Introduction  
Most AAA’s are asymptomatic and are usually detected accidentally during 
physical examination. Large AAA’s may be detected clinically by careful palpation or 
feeling of the abdomen, which may reveal an abnormally wide pulsation of the 
abdominal aorta. In overweight people, aneurysms can be very difficult to detect on 
physical examination. 
Aneurysms on the verge of rupture when they are rapidly enlarging, they are 
often tender. Listening with a stethoscope may also reveal a bruit or abnormal sound 
from turbulence of blood within the aneurysm. Symptoms only occur near to or at 
point of rupture. These include lower abdominal, back or testicular pain, nausea and 
vomiting, feeling of coldness in the legs, profuse sweating and hypotension post 
rupture. (70) 
An abdominal aortic aneurysm needs diagnostic imaging to be diagnosed and 
accurately measured. The first method of choice is ultrasound as it is non-invasive. 
Ultrasound has been shown to be a reliable and a cost effective method in the 
diagnosis of AAA. 
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2.1 Ultrasound for AAA diagnosis 
In a clinical setting Ultrasound is said to be the most practical, non-invasive 
and inexpensive modality in screening for and surveillance of AAA , with a sensitivity 
of 98.9% and specificity of 99.9% (9, 71,72). Ultrasound can reliably image the aorta 
in 99% of patients (73), however it is highly operator dependent.  
Real-time ultrasound provides the examiner with a two-dimensional greys-
scale image of the abdominal organs and vasculature. It is possible to image 
anomalies of arterial location and arterial course as well as pathologically dilated 
segments. Information can be gathered about the extent of aneurysms from cross-
sectional measurements in different planes and these values can also be used in 
relevant follow-up examinations. 
Significant portions of the abdominal aorta are not visualized on emergency 
due to non-fasting patients and the presence of bowel gas etc. This rate is higher 
than reported for fasting patients receiving elective ultrasound for evaluations of their 
aortas. 
Ultrasound is not very accurate in determining the presence of a leak from an 
aneurysm. A rAAA can be indicated by the presence of free fluid in potential 
abdominal spaces. However, contrast enhanced CT is required for confirmation. 
Duplex and colour flow Doppler ultrasound examinations of the abdominal 
cavity are highly dependent on the clear display of the tissues and vascular structure 
provided by B-mode ultrasound. B-mode is often used on its own in abdominal 
ultrasound to detect arteriosclerotic wall plaques and aneurysms of the abdominal 
aorta and pelvic arteries. 
The more echogenic structures within the vascular lumen can be recognized 
due to their strong ultrasound reflection when compared to blood. This makes 
sonographic imaging of morphological wall changes of varying pathology possible as 
they occur in various types of aneurysm, including walls deposits (plaques) and also 
parietal thrombi. 
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Doppler mode and colour flow are not necessary tools in AAA diagnosis but 
can be helpful in identifying the iliac arteries. (Figure 2.1 Figure 2.2) 
 
Figure 2.1 Transverse B-mode image of an AAA, with an anterior posterior 
measurement. 
 
 
Figure 2.2 Longitudinal B-mode image of an AAA 
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2.1.1. Limitations of Ultrasound 
Major limitations with ultrasound are that it cannot travel through bone, air or 
gas. In AAA scanning is the presence of bowel gas and obesity can obscure the 
imaging. Patients who are obese are more difficult to image as the sound wave 
attenuates as it passes deeper into the body, therefore leading to suboptimal imaging 
and inaccurate measurements being obtained. 
Intestinal gases also prevent visualization of deeper structures. Calcification 
of the artery can also obscure the image as the beam may not be able to penetrate 
the artery, therefore not giving a clear view of the arterial wall. Tortuosity can also 
impede the imaging, making it difficult to follow the course artery. The scan is also 
operator dependent, inter observer error can lead to inaccurate measurements of 
AAA and therefore maybe misleading in AAA growth on follow up scans. Performing 
an inter observer error test is vital to assess the error of measurement between 
fellow technologists in a scan center. Detailed knowledge of image optimization (the 
max amount of depth and width required to view the aorta etc) is also necessary to 
attain a clear image and accurate measurements. Therefore it is important that a full 
train vascular technologist performs the scanning in a screening setting. It is vital the 
machine settings are correct for the scan being performed. To ensure the best 
possible image is obtained.  
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In synthesis: 
Advantages: 
 Unlike CT, ultrasound does not use x-rays or any other kinds of 
potentially harmful radiation. 
 Ultrasound equipment can produce moving images in real-time. 
 Ultrasound has been used for abdominal examinations for about 40 
years, and for standard diagnostic ultrasound there are no known risks 
or harmful effects to humans. 
 Ultrasound is a cost-effective means of image acquisition in medicine. 
 
Disadvantages: 
 The patient has to undergo a slightly more intrusive session than is the 
case with a CT session, including the removal of clothes and 
application of the gel. 
 The quality of the recorded images is dependent on the operator’s skill 
of handling the equipment. 
 
Limitations: 
 Ultrasound imaging produces images that are far inferior in quality to 
CT. Proper identification of structures and regions in the finalized 
ultrasound images generally requires personnel with expertise and 
training to do so. 
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2.2 Computed Tomography (CT) 
Computed Tomography is based on the principle of attenuation. It is 
composed of a large ring containing x-ray sources and arrays of detectors which 
rotate around the patient. Multiple Xray fan-beam sources send out ionizing radiation 
into the patient’s body. Attenuation occurs and the array detectors then process the 
beams post attenuation. The level of attenuation depends on the density of the 
medium (e.g. muscle is denser than blood). The arrays mathematically construct the 
image by numbering the attenuations detected. The larger the number, the more 
dense the medium and the lighter the shading on the image.  
This method happens in 4 steps: 
Step 1: The tube and detectors are rotated at a constant speed. 
Step 2: The x-ray tube is energized and data collected for 360 degrees. 
Step 3: The tube and detectors slow down and come to a stop. 
Step 4: The table and patient are indexed to the next scanning position. 
(Figure 2.3) 
 
Figure 2.3 Components of a CT machine 
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CT gives a digital, transverse (trans axial) image. It is composed of slices of 
cross-section views. Computed tomography scanning creates superb images of the 
brain, bone, lung and soft tissue and it doesn't allow information from irrelevant 
locations to enter the acquired data. (Figure 2.4) 
 
  
Figure 2.4 CT image of an AAA  
 
Contrast-enhanced CT is widely used in the preprocedural imaging of AAA’s. 
The 3-D images obtained from the CT are also used in the planning of endovascular 
procedures. It involves the use of CT and the injection of a high speed contrast 
media. This procedure is used in the assessment of the arterial tree, as the contrast 
agent highlights a narrowing in an artery. In AAA imaging it shows the dilation of the 
aorta, it allows the accurate measurement of the diameter of the aneurismal section 
and the length of the vessel involved. (Figure 2.5) 
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Figure 2.5 3-D reconstruction images of an AAA  
 
The advantage of contrast-enhanced CT imaging is the accurate assessment 
of the blood vessels, giving detail to the location and length of the affected vessel. 
However there are many disadvantages to CT contrast imaging: 
1.  It is highly invasive. 
2.  The patient may be allergic to the iodine contrast agent. 
3. During CT imaging the patient is exposed to high doses of ionizing 
radiation. 
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In synthesis: 
 Advantages: 
 CT examinations are fast and simple and can quickly reveal internal 
injuries and bleeding. 
 CT imaging has been shown to be a cost-effective tool for a wide range 
of clinical problems. 
 CT imaging offers detailed views of many different kinds of tissues. 
 CT imaging is painless, noninvasive and accurate. 
 Through use of CT scanning, it is possible to identify both normal and 
abnormal structures. This makes it a useful tool for guiding radiotherapy, needle 
biopsies and other minimally invasive procedures. In many cases this can eliminate 
the need for invasive surgery. 
 
Disadvantages: 
 CT involves exposure to radiation in the form of x-rays. The typical 
radiation dose from a CT exam is equivalent to the natural background radiation 
received over a year’s time. Special care must be taken during x-ray examinations 
and the patient’s abdomen and pelvis should normally be shielded by a lead apron.  
 CT exams are generally not recommended for pregnant women. 
 
Limitations: 
 Very fine details in soft tissue cannot always be seen with CT imaging. In 
some situations, soft tissues may be obscured by bone structures. In these cases, 
magnetic resonance (MR) imaging may be preferable. 
 Using CT imaging as a means of guidance during patient surgery is 
inconvenient, as the patient will have to be moved in and out of the CT scanner each 
time an updated image is needed. 
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2.3 Ultrasound verse CT 
Ultrasound is the method of choice in screening and AAA surveillance as it 
avoids high doses of radiation and minimizes costs compared to computed 
tomography (CT). (71, 74-76). 
CT has been a widely used tool in the diagnosis and detection of AAA. 
However it is an expensive, time consuming method with high doses of radiation 
being given to the patient. Ultrasound is a quick, inexpensive and non-invasive 
method which is more suitable in diagnosis and screening for AAA (77). CT is gold 
standard preoperatively as it accurately measures the diameter of the proximal neck 
of aorta, diameter and length of the aneurysm, diameter of the aorta just before the 
bifurcation, length from the aneurysm to the bifurcation and diameters and length of 
the iliac and femoral arteries. The use of CT provides accurate configuration of stent 
grafts for the individual’s anatomy. (78) 
Ultrasound has also been shown to be the method of choice for measuring 
maximum AAA diameter. Ultrasound and CT do not always take the measurement on 
the same axis (77). CT takes the max cross-sectional area at any point, ultrasound 
takes the largest diameter in anteroposterior or transverse aspects (71).CT takes an 
oblique cut of the aneurysm to measure the max diameter, if the AAA in angulated 
more than 25 °, the diameter measured by the CT will be overestimated. (71, 77). 
Ultrasound is less effected by a tortuous vessel as the probe can be tilted to get a 
more accurate cross sectional area. (71, 77). 
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2.4 Role of Positron Emission Tomography (PET)   
PET imaging was developed in the mid-1970s; like any nuclear medicine 
imaging technique, it is based on the detection of photons emitted by the patient after 
administration of a radio-labelled tracer. Several physical characteristics of PET 
constitute a major advantage over monophotonic scintigraphy. Most importantly, the 
tracers are labelled with positron-emitting radionuclides. The two photons resulting 
from the disintegration of the positron are emitted in opposite directions (i.e., at 1800 
from each other) and recorded in coincidence by the detectors surrounding the 
subject. A detailed description of the specific technical and methodological features 
of PET imaging is obviously beyond the scope of this article and may be found in 
Phelps (78). In short, PET imaging increases the count rate (i.e., the number of 
photons that are detected) and improves the spatial resolution, that is, lesion 
detectability. In addition, the images can be fully corrected, in particular for 
attenuation, which allows for an accurate and reproducible quantitation of tracer 
distribution.  
Depending on the radiotracer, a wide variety of physiological and pathological 
processes can be studied at the molecular level using this technique. However, in 
routine clinical practice, vast majority of PET studies are performed using 18-F-
fluorodeoxyglucose (FDG), which reflects glucose uptake and metabolism resulting 
from cellular activity. 
FDG is a glucose analogue, transported into cells using glucose transporters. 
Once inside the cells, FDG is phosphorylated to FDG-6-phosphate, which is not a 
substrate for the enzymes of the glycolytic chain, and hence FDG-6- phosphate 
accumulates within the cell. FDG-PET recognizes increased metabolic activity and is 
mainly used for cancer imaging. Indeed, cell glucose metabolism is significantly 
increased in most types of cancer (79) due to increased expression of membrane 
transporters, increased hexokinase activity or both. Nevertheless, FDG uptake is not 
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specific for tumours. Increased uptake is observed in many nonneoplastic 
physiological and pathological conditions (80). 
Usually, the level of FDG uptake by inflammatory cells in the resting state is 
low in comparison with tumour cells. However, when activated, these cells may show 
significant increases in glucose uptake and metabolism. This has been evaluated in 
various experimental settings, including skin transplantation, turpentine-induced 
inflammation, concavalin- A activation of T lymphocytes in bacterial abscesses or in 
B lymphocytes after viral infection. The lack of specificity for tumours provides a 
powerful tool for using PET to evaluate inflammatory and infectious diseases as well 
as during the monitoring of vascular graft infection (81-83). It should be noted, 
however, that FDG uptake is often seen in the arterial wall, in the absence of  any 
known inflammatory vascular disease. Yun et al. evaluated two series of patients 
who underwent PET imaging for oncological or other indications. They found that the 
rate of positive vessel uptake approached 50% and increased with age (84). They 
also showed that hypercholesterolaemia and age were the only parameters 
correlated with the presence of such uptake, among all major risk factors for 
atherosclerosis (85). 
With the advent of modern PET/CT, the procedure has been considerably 
shortened and simplified. Usually, patients are asked to fast for 6 h prior to injecting 
FDG, which is of particular importance when investigating inflammatory processes, 
as glucose loading significantly decreases glucose transporter expression (and FDG 
uptake) in inflammatory lesions (86). Modern hybrid scanners are coupled with CT for 
attenuation correction and anatomical mapping. Attenuation correction is usually 
performed using data from continuous, enhanced, low-dose body CT from the skull 
base to the thighs. Intravenous contrast enhancement can be used with limited 
effects on attenuation correction and uptake quantification in order to provide 
additional information on the thrombus, surrounding tissues and vessels. 
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Wu et al. (87) demonstrated the uptake of 18F-FDG in the unstable 
atherosclerotic carotid plaque and correlated this with levels of circulating matrix 
metalloproteinase 1 (MMP- 1). Other workers have shown the high uptake of FDG 
into vulnerable atherosclerotic plaque and the reduction of carotid FDG uptake after 
statin therapy. This suggests that PET imaging might have clinical utility in monitoring 
atherosclerotic arterial disease (88). 
 Using autoradiographic techniques, Rudd et al. showed increased tracer 
accumulation in the regions of the plaque with the highest density of macrophages 
(89). Indeed, enhanced uptake has been reported in various inflammatory diseases 
involving the large vessels. Giant cell arteritis and Takayasu arteritis both show 
significantly increased glucose metabolism in the wall of the affected arteries (i.e., 
aorta, subclavian arteries or carotid arteries). Furthermore, FDG uptake has been 
found in large arteries in the presence of active atheromatous plaques (84, 85). 
In a pilot study, Sakalihasan et al. observed an association between 18-FDG 
uptake by the aneurysm wall and rapid expansion of the aneurysm in some cases 
(90). Indeed, five of the nine operations on patients with positive PET imaging were 
performed on an urgent basis. In the 16 PET negative patients, aneurysmal repair 
was delayed for the convenience of the patient from one to several months. None of 
these patients developed aneurysm-related symptoms in the interval. 
FDG uptake in the aneurysm wall reflects the presence of increased 
metabolic activity, probably associated with a high density of inflammatory cells 
(macrophages, lymphocytes, etc.) in the adventitia, as previously described (91). 
These preliminary observations have been confirmed recently in a study by Reeps et 
al. (92) where they observed a correlation between increased FDG uptake and 
patients with a very high macrophage activity and symptomatic AAA. However, in 
agreement with earlier reports (90) Reeps et al. failed to find a correlation between 
the maximum standard uptake value (SUV) and maximum cross-sectional infra-renal 
AAA diameter (92). These studies could suggest a possible correlation between 
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increased FDG uptake by the aneurysm wall and inflammatory cell biology leading to 
rupture. 
Therefore, PET scanning with FDG uptake offers a new tool for exploring 
adventitial immuno-inflammatory responses in atherosclerosis and AAA. 
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Chapter III 
Treatment of AAA’s 
 
3. Introduction  
AAA’s are generally asymptomatic and are usually diagnosed as incidental 
findings during physical examinations for other conditions. The treatment of AAA 
varies depending on the size of the AAA and the risk factors of the individual patient. 
 
3.1 Medical Therapy 
At present there are no pharmacological treatments available to prevent AAA 
formation, growth and rupture. However, treating cardiovascular risk factors has been 
shown to prevent AAA’s or reduce the progression of an already existing AAA. 
When treating the risk factors, there are conflicting arguments whether statins 
are beneficial in slowing the growth of AAA’s. Statins are generally used to lower 
cholesterol by inhibiting the enzyme involved in the synthesis of cholesterol in the 
liver. Studies have reported the use of statins to reduce the inflammatory response of 
macrophages, T lymphocytes and MMP and thus reducing AAA progression (57, 94, 
95). Other studies show that lipid lowering drug treatments can delay growth in small 
AAA’s (56). While others report that the use of statins, do not help in reducing AAA 
growth or changes in AAA wall composition (16, 46, 96). 
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3.2 Operative Treatment 
Surgical repair of AAAs can be classified according to symptoms prior to 
surgery in five groups: 1) elective asymptomatic, 2) elective symptomatic, 3) 
emergent repair without rupture, 4) rupture without clinical shock and 5) rupture with 
clinical shock (97). Perioperative mortality is lowest in group 1 and highest in group 5. 
In practice, AAA repairs are often divided into elective AAA repair (groups 1 and 2) 
and emergent AAA repair (groups 3-5), or into Intact Abdominal Aneurysm (iAAA) 
repair (groups 1-3) and Ruptured Abominal Aneurysm (rAAA) repair (groups 4 and 
5). 
 
3.2.1 Intact AAA repair. 
The adequate AAA size at which elective repair is recommended in 
asymptomatic patients has been established to 55 mm in two large, randomized 
multi-centre studies (58, 66,  98). However, an individual approach is recommended, 
where the operative risk of the patient is balanced against risk of rupture and 
expected long-term survival.  
Elective operative treatment is associated with a perioperative mortality of 2-
5% in large randomized or population-based studies (56, 66, 99). National variations 
in perioperative mortality after AAA repair exist in register data (100). Short-term 
outcome is highly dependent on patient comorbidities, and mortality is increased in 
patients with renal dysfunction, cardiac disease and pulmonary dysfunction (101). In 
addition, increased age and female gender are associated with higher short-term 
mortality.  Most but not all (8) reports indicate a reduced operative mortality after 
iAAA repair over time (102, 103). A minority of iAAA repairs are performed in 
symptomatic patients e.g. with tender aneurysms. In these cases operation is 
performed as an urgent intervention, and the perioperative mortality is approximately 
twice as high as in elective asymptomatic repair (100). 
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Based on the Swedvasc, time-trends for AAA repair in Sweden between 1994 
and 2005 were recently reported (104). During this period, the incidence as well as 
the total crude number of operations performed for iAAA increased significantly. This 
was mainly due to the introduction of Endovascular Aneurysm Repair (EVAR), as 
discussed below. In addition, patient demography changed over time with an 
increase in mean age of AAA patients and a higher proportion of octogenarians being 
treated. The 30-day mortality rate decreased steadily over the studied time-period, 
both after iAAA and rAAA repair. Changes in patient demography could, however, 
affect long-term survival after AAA repair, potentially reducing the expected benefit 
for the patients. Long-term survival is fundamental for surgical decision-making, and 
has an important health economic implication when evaluating the cost-effectiveness 
of a new treatment (e.g. EVAR) or health intervention (e.g. screening for AAA). 
There are two different methods for treatment of AAA: open reaper (OR) and 
Endovascular Aneurysm Repair (EVAR). There are advantages and disadvantages 
with both techniques. OR is associated with a higher perioperative mortality and 
morbidity, as well as longer ICU and hospital stay than EVAR (99, 105). While EVAR 
has several advantages in lower perioperative mortality and morbidity, this treatment 
is associated with a higher rate of re-interventions and need for close follow-up (99). 
Due to the novelty of the method and the rapid development of the endovascular 
technique, long-term durability of EVAR is not as well-known as after OR. In addition, 
EVAR is associated with certain requirements in aneurysm morphology, most 
importantly a need of an aneurysm neck as a proximal sealing zone for the 
endovascular stent graft.  
Approximately 30-50% of all AAAs are currently regarded as not possible to 
treat with EVAR (although this varies considerably between centers), and future 
development of the technique might decrease this proportion (99, 105). Current 
practice at many centers is to select patients to OR or EVAR based on aneurysm 
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morphology as well as patient age and comorbidities. Patients treated with EVAR are 
typically older and have more comorbidities than those treated with OR (104). 
 
 
Figure 3.1 Number of elective AAA repairs in Sweden with open (OR) and 
endovascular (EVAR) technique (Swedvasc, 2008). 
 
Since the introduction of EVAR in 1986, an increasing proportion of AAA 
patients are being treated with endovascular technique. Data from the Swedvasc 
indicate an increase of 53% in the total number of elective repairs and 189% in the 
number of EVARs in Sweden over the years 2003-2007, Figure 3.1 (106). In 2008, 
53% of all elective AAA repairs in Sweden were performed with EVAR (106). 
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3.2.2 Ruptured AAA repair 
The operative mortality after rAAA repair is approximately 35% (104). 
However, only 1/3 of patients with AAA rupture undergo operation while the 
remaining patients die without surgical attempt. 
The overall mortality after AAA rupture is thus around 80% (58). Some groups 
have reported stable mortality rate after rAAA repair (8, 21, 102), whereas others 
have found a decreasing mortality over time (103, 104). Endovascular repair for 
ruptured aneurysm is increasing and constituted 25% of all rAAA repairs in 
Swedvasc 2008 (106). The feasibility of endovascular technique in an emergency 
setting has been established in several reports. There is a great variety in use of 
EVAR for rAAA, and some centers treat a high proportion of all ruptures with this 
technique (Holst, 2009). However, it is difficult to compare the results of emergency 
EVAR to OR due to the effect of patient selection and the difficulty to perform 
randomized clinical trials in this acute setting. Large randomized clinical trials 
comparing OR and EVAR for rAAA are in progress. 
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Chapter IV  
Rupture criteria in a clinical setting  
 
4. Introduction  
The indication for elective repair is strongly related to the aneurysm’s risk of 
rupture, and although maximum diameter is the current criteria for treatment, no 
general consensus exists on the critical size beyond which elective repair is 
recommended. In each case, the risk of rupture must be weighed against operation 
morbidity. Therefore, a single threshold diameter is not appropriate for every patient 
hence the assessment of the risk of rupture should ideally be individualized to better 
manage aneurysm patients.  
Current clinical practice recommends to repair large AAA, with maximum 
transverse diameter larger than 55 mm, or to regularly monitor smaller AAAs 
(diameter less than 55 mm) with ultrasound. However, small aneurysms can also 
rupture, with an associated mortality rate of up to 50% (107). Moreover, the 12-year 
follow-up of the UK Small Aneurysm Trial reported an overall mortality of 67.3% for 
the surveillance group (98).  
These findings question the ability of maximum diameter criterion to assess 
AAA risk of rupture. Several reports demonstrated the existence of a risk of rupture of 
AAA below 55 mm in diameter and showed that rapid aneurysm expansion is 
associated with increased rupture risk independently of their size (108).  
In common clinical practice expansion rate of an AAA is generally defined as 
the change in maximum aortic diameter over time.  
Limet et al. (109) associated the risk of rupture of AAAs with aneurysm 
expansion rate and different studies reported an increased mean expansion rate in 
patients with ruptured AAAs (24, 66).  
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Realistic AAAs have complex, tortuous, and asymmetric shapes with local 
changes in surface curvature (110-112) and the maximum-diameter measures at two 
time points only provides limited information regarding aneurysm growth. Specifically, 
it might miss regions of fast diameter growth, it cannot quantify axial growth, and it 
cannot capture shape changes of potential interest for EVAR-related decisions (113).  
Stenbaek et al. (114) investigated the ILT growth as a potential rupture risk 
predictor and concluded that a rapid increase in ILT area may be a better predictor of 
AAA rupture than an increase in maximum transverse diameter.  
So far, both aneurysm rupture and growth are unpredictable by the diameter 
alone. Better predictors for rupture and growth are required and may be found in a 
more extended patient-specific analysis, based on biomarker and biomechanical 
information. This may lead to an optimization of both the follow-up plan and the 
moment of aortic repair. 
 
4.1 Biomarkers 
More insight in the pathogenic pathways of aneurysm formation and 
progression may be gathered by evaluating circulating biomarker concentrations 
(115, 116). Circulation matrix metalloproteinase-9 (MMP-9) concentrations have 
been investigated most frequently in association with AAA. 
As we see in the next chapter MMP-9 is involved in the breakdown of the 
extracellular matrix and, in most studies, was found to be elevated in AAA’s 
compared to healthy subjects (115). Also, the tissue inhibitor of MMP 1 (TIMP-1) was 
found to be increased in AAA patients compared to healthy controls (117).  
The markers of inflammation interleukin-6 (IL-6) and C-reactive protein (CRP) 
are frequently studied in cardiovasculair disease and were found to be elevated in 
the presence of AAA in most studies (115). Besides, serum CRP concentration was 
also associated with the size of AAA (118). 
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Also, AAA growth was investigated in relation to biomarkers. Again, MMP-9 
was correlated with AAA expansion rate (119). In the same study was found that 
alpha 1-antitrypsin (α1-AT) was weakly correlated with AAA expansion rate (119). 
 α1-AT is an inhibitor of alpha 1-trypsin, which inhibits elastase. Elastase, on 
its turn, actively breaks down elastic fibers in the aortic wall. 
Biomarkers as predictor for AAA rupture have been relatively little 
investigated.  
Engstrom et al. (120) concluded that the incidence of fatal or repaired AAA 
was associated with a higher number and levels of inflammation-sensitive plasma 
proteins. CRP levels in patients with symptomatic or ruptured AAA’s were 
significantly higher than in patients with an asymptomatic AAA (121). Also, MMP-1 
and MMP-9 were elevated in the plasma of ruptured AAA versus non-ruptured AAA 
and elevation of MMP-9 was associated with ruptured AAA related 30-day mortality 
(122). 
Numerous studies have focused on measuring biomarker concentrations in 
order to predict AAA presence, growth or rupture, but most studies have not 
assessed the value of these markers as diagnostic tests for AAA (115, 116, 118). 
Biomarkers may play a role in the identification of small AAA’s. Additionally, 
when biomarkers associated with AAA are identified, targeted medical treatment may 
be developed to slow down AAA progression. For now, sensitivity and specificity 
appear inadequate for the use of single biomarkers alone in diagnosis (115). 
Using multiple biomarkers in combination with other AAA related factors may 
in the future prove to be of value in the diagnostics of AAA. 
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4.2 Biomechanical Analysis 
From a biomedical engineering point of view, biomechanics play an imminent 
role in rupture of the AAA wall. When the stress on the AAA wall, caused by the 
blood pressure, locally exceeds the strength of the wall, rupture of the wall occurs. 
The law of Laplace states that the wall stress in a thin-walled cilinder linearly 
increases with increasing diameter and transmural pressure, and decreases for 
increasing wall thickness. However, due to the complex geometry of most AAA’s, the 
wall stress is determined by the local AAA geometry and wall thickness, and can 
therefore not be predicted by the law of Laplace, or be based on simplified 
geometrical models (123). 
Recent studies showed that peak wall stress (PWS) in AAAs is a more 
reliable parameter than maximum transverse diameter for aneurysm rupture 
prediction (124-127). Simulations of anatomically realistic AAA models were 
performed to compare PWS between ruptured or symptomatic and unruptured 
aneurysm cases (124, 128). These studies found a significant difference between the 
two groups. The PWS for ruptured aneurysms is about 60% higher than for non-
ruptured and the location of the PWS correlates with the site of rupture (127).  
However, it is necessary to underline that wall stress alone is not sufficient to 
predict rupture risk; regional estimations of wall strength would also be necessary 
(130). It has previously been shown that wall strength differs significantly from 
patient-to-patient and within the same aneurysmatic sac (129, 130). In addition, Di 
Martino et al. (131) found that the strength of the aneurysmatic wall from ruptured 
AAA cases is considerably lower than that for electively repaired ones. In this regard, 
Vande Geest and colleagues (129) have proposed a statistical model to 
noninvasively evaluate the wall strength distribution in AAA taking into account 
factors such as gender, age, family history, AAA size and local ILT thickness.  
However, based on the principles of material failure knowledge of both, AAA 
wall stress distribution and wall tissue strength are necessary to assess rupture 
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potential, and different biomechanical rupture risk indicators have been suggested in 
literature (125, 129, 132).  
Another factor of significant importance in AAA rupture risk prediction is the 
non-uniformity of the wall thickness. In fact, AAA wall has considerable regional 
variation in wall thickness with a reduction in wall thickness near the rupture site. 
Moreover a significant difference in wall thickness was found between ruptured and 
electively repaired aneurysms, as well as an inverse correlation between wall 
thickness and local tissue strength (131, 133).  
Due to the inability to measure wall thickness noninvasively, a uniform 
thickness is typically assumed in biomechanics modeling of AAAs. Other significant 
limitations of previous studies include the use of isotropic tissue constitutive law (134) 
and of a load-free reference configuration.  
Although an ILT is known to be an important solid structure that influences 
AAA wall stress distribution it has been disregarded in many biomechanical AAA 
models.  
Advances in medical imaging, provide good information to perform patient-
specific vascular geometries reconstructions (135, 136) and an accurate 
characterization of the aneurysm shape with the variation of wall thickness (110, 127) 
need to be accounted for the assessment of AAA rupture. In particular the 
assumption of constant distribution of wall thickness causes an underestimation of 
the PWS (138, 139). Moreover, accounting for the ILT and the non-homogeneous 
distribution of tissue strength and wall thickness in AAA models, reinforced the 
predictability of FE simulations, which allowed for a statistically significant 
discrimination between ruptured and non-ruptured AAAs (125). 
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Chapter V 
Arterial Wall   
 
5.1. Pathophysiology Anatomy of the normal aorta and regional features 
that predispose to aneurysm 
The walls of every artery, including the aorta, consist of 3 layers: the tunica 
intima, tunica media, and tunica adventitia (usually called the intima, media, and 
adventitia).  
The intima is the innermost layer, right next to the flowing blood. This layer is 
composed of a single layer of endothelial cells anchored by connective tissue to the 
layer immediately below, which is the media. The media consists of smooth muscle 
cells and elastin fibers, collagens, and other connective tissue molecules. The third 
and outermost layer, the adventitia, consists of fibroblasts, various hematopoietic 
cells, neurons, small capillaries, and connective tissue. The cells of the aortic wall are 
provided with nutrition and oxygen via small capillaries called vasa vasorum. Aortic 
vasa vasora, however, are present in the thoracic region, but not below the renal 
arteries. Instead, the cells in the wall of the abdominal section of the aorta are 
supplied by diffusion from luminal blood. 
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Figure 5.1: A section of normal aorta stained with Masson’s Trichrome 
technique, in which smooth muscle cells appear red, collagen stains light blue, and 
the cell nucleolus appears dark blue. 10 times magnification. 
 
It has been suggested that different segments of the aorta arise from different 
embryonic origins. In a study of murine embryos, vascular smooth muscle cells in 
various sections of the vasculature had different embryonic origins. In particular, the 
abdominal aorta diverges from the thoracic aorta. Smooth muscle cells in abdominal 
region of the aorta originate from mesoangioblasts, while smooth muscle cells from 
the abdominal aorta and femoral arteries originate from somites and various stems 
cells respectively (145, 146). Whether the different origins of vascular smooth muscle 
cells affect the characteristics of these cells and the predisposition to aortic diseases 
are not known. Nevertheless, some authors have speculated that the embryonic 
origins of the abdominal aorta may partly explain why it is far more likely to become 
aneurysmal than its neighboring sections.  
In addition, the amount of elastin is not uniform along the length of aorta. The 
further from the heart, the fewer the elastin fibers there are in the aorta (147). This 
observation was first made in 1928, when Alfred Benninghoff investigated the 
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amount of elastin along the length of the human aorta and discovered a decrease in 
the amounts of elastin and collagen from proximal to distal aorta. Benninghoff 
estimated 60-80 layers of elastin in the ascending aorta, but only 20 layers in the 
infrarenal aorta. 
In a later study, the infrarenal aorta was reported to have 58% fewer elastin 
layers, compared to the suprarenal aorta, and the infrarenal aorta exhibited the 
lowest proportion of elastin to collagen (148).These observations provide an 
additional explanation why most aortic aneurysms are seen in the infrarenal region. 
Further evidence for structural weakness in the abdominal aorta comes from 
a study, in which the researchers used ultrasound to compute wall stress in the 
abdominal aorta and common carotid arteries of 111 healthy individuals between 
ages 25-70 years. Measurement of luminal diameter and intima-media thickness of 
these vessels showed that age was associated with increasing diameter of the all of 
these arteries, but was compensated by additional thickness of the wall of the 
common carotid arteries, and so wall stress in these vessels remained constant with 
age. Some wall thickening was seen in abdominal aortae of older men, but was 
insufficient to fully compensate for the stress from increased vessel diameter. Thus, 
wall stress in the abdominal aorta increased with age in men and may contribute to 
the development of AAA in elderly men (149). 
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5.2. Cells in the normal and aneurysmal aorta 
The normal aortic wall contains endothelial cells, smooth muscle cells, and 
fibroblasts. 
Histological studies show that segments of AAA are not lined with endothelial 
cells (e.g., see Figure 5.2).  
 
Figure 5.2: A section of aneurysmal abdominal aorta stained with Masson’s 
Trichrome technique. Compared to the normal segment in Figure 5.2, smooth muscle 
(red) is decreased, and collagen (light blue) is increased. 10-times magnification. The 
arrow indicates neovascularization. The red region on the outer right surface is the 
remnant of an intraluminal thrombus, the majority of which had been removed during 
open repair. 
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Aneurysmal vessels contain smooth muscle cells, but in decreased amounts 
(150), and mRNA expression of alpha actin is lower in AAA vessels compared to 
healthy vessels (151). Importantly, AAA segments contain platelets and inflammatory 
cells, particularly macrophages, neutrophils, and mast cells. These cells are rarely 
found in normal aorta. Platelets together with inflammatory cells produce proteases 
that may further damage the vessel (152). 
A comparison between Figure 5.1 and 5.2 shows clearly that the aneurysmal 
wall is distorted, and the number of smooth muscle cells (red) is decreased 
substantially, while collagen (blue) is initially overproduced. 
 
5.3. Matrix of the Aorta 
There are several macromolecules comprising the extracellular matrix of the 
aorta. Among them are laminin, various types of proteoglycans, fibronectin, collagen, 
and elastin. The relevant macromolecules are elastin and collagen types I and III. 
These molecules provide elasticity and strength to the aortic wall, enabling it to store 
energy by distending during systole, and then recoil back during diastole, thereby 
maintaining systemic blood pressure while the left ventricle is relaxing and the aortic 
valve is closed. 
While elastin provides physiological strength in the form of elasticity to the 
vessel wall, collagen is required for mechanical strength at higher pressure and 
provides rigidity to the vessel. It has been shown that canine models of AAA induced 
by treatment of the aorta with elastase show dilatation without rupture, whereas 
treatment with collagenases resulted in less dilatation but was followed by rupture 
(66). 
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5.3.1 Elastin 
Elastin, a macromolecule in the medial layer of the aorta, enables the vessel 
to absorb the pulsatile energy from the heart, to increase aortic diameter at systole 
and regain its initial shape during diastole. Elastin is produced at early stages of 
infancy and must last throughout lifetime of an individual. Production of elastin in the 
aorta later in life has not been detected. Elastin has a high threshold for 
environmental assaults i.e. temperature and chemicals and has a half-life of 40 years 
(154). 
It has been suggested that the first event in the onset of AAA is loss of elastin 
(155). Histological studies show that AAA walls contain markedly reduced amounts of 
elastin, which is a result of the activity of elastases. The presence of neutrophil  
elastase (NE) originating from polymorphonuclear cells in AAA tissue has been 
shown to cause degradation of elastin (156).  In addition, matrix metalloproteinases 
(MMPs) and cathepsins (157) also have the ability to degrade elastin (158). It has 
been suggested that all the above-mentioned proteases have a role in loss of 
elasticity of the aortic wall and the increase of AAA diameter (159, 160). 
Elastase-derived peptides (EDPs), which are produced by degradation of 
elastin, show an increased abundance in AAA compared to normal aorta (161). 
Moreover, EDPs have been shown to recruit inflammatory cells, which in turn 
produce more proteases that continue the degradation of elastin, leading to a vicious 
cycle (62, 163). The imbalance between protease and inhibitor exacerbates the 
progression of AAA (164). 
Two experimental mouse models of AAA rely on artificial damage to aortic 
elastin. In the elastase model, the infra-renal abdominal aorta of mice is briefly 
clamped off, porcine elastase is injected into the lumen, and after a brief incubation, 
the elastase is rinsed out and normal blood flow restored. This manipulation induces 
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aneurysm formation and lasting within 2 weeks of the procedure (165). In the calcium 
chloride (CaCl2) model, the aorta is exposed to a CaCl2 solution placed briefly on the 
adventitial surface. The CaCl2 provokes an inflammatory reaction that disrupts the 
elastic network, leading to degradation of elastin (165). The aorta becomes 
aneurismal, but in the mouse, it is reversible, and the aneurysm regresses to its 
original size after 6 weeks. 
 
5.3.2 Collagen 
Another major component of the connective tissue that gives the aorta its 
strength and rigidity is collagen. There are several types of collagen, but collagen 
types I and III are the predominant types in blood vessels. Degradation of collagens 
is a result of the activity of collagenases, such as MMP1, MMP8, and MMP13, all of 
which have been found in AAA tissue (166). Collagenases are capable of initiating 
the degradation of intact, triple-helical collagen. Once collagen degradation has 
begun, a second set of enzymes, called gelatinases, are able to digest partially 
degraded, denatured collagen. 
Gelatinases include MMP2 and MMP9 (167). Degradation of elastin and 
collagen triggers the production of collagen in the AAA wall (168, 169), and so there 
is an initial increase in aortic collagen content (see Figure 5.2). As AAA progresses, 
however, the degradation of collagen overwhelms its production, leading to rupture 
(170). 
During the development of AAA, the structure of the vessel wall is disrupted 
and the wall weakens (Figure 5.2). At later stages, production of extracellular matrix 
is decreased owing to apoptosis of smooth muscle cells, while at the same time, 
continued degradation of elastin and collagen renders the AAA wall thin (150). 
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Rupture occurs when the components of the disrupted aortic wall fail to withstand the 
mechanical stress from pulsatile blood flow. 
 
5.4 Proteases and their inhibitors 
Some of the most important proteases are introduced in Table 1, below, along 
with their inhibitors and known substrates. 
Table 1: Proteases studied in this thesis, their inhibitors, and substrates (Brew 
and Nagase 2010; Shiomi, Lemaitre et al. 2010) 
Protease inhibitor substrate 
Elastase α-1 antitrypsin Elastin, Fibrin 
MMP1 TIMP1-4 
Collagens I, II, III, VII, X, 
entacin, aggregan, perlecan, 
MMP2 TIMP1-4 
Gelatins, collagens IV, V, VII, X, 
XI, Fibronectin, Laminin, 
MMP9 TIMP1-4 
Gelatins, collagens III, IV, V, 
elastin, aggregan, vitronectin 
MMP13 TIMP1-4 
Collagen I, II, III, IV, IX, X, XIV, 
Fibronectin, Laminin, 
ADAM10 TIMP1-3 
ProTNF-α, delta, collagen IV, 
gelatin Mylein basic protein, 
ADAM17 TIMP1-3 
ProTNF-α, ProTGF-α, TNF-p75 
receptor, TRANCE, 
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5.4.1 Neutrophil elastase: its role in coagulation/fibrinolysis and its inhibition 
by α-1-antitrypsin 
Neutrophil elastase (NE) is a serine protease produced by polymorphonuclear 
neutrophilic leukocytes (neutrophils) and stored in their azurophilic granules. This 
protein is released during inflammation and has the capacity to degrade extracellular 
matrix, especially elastin. It also has anti bacterial activity. Elastin derived peptides 
(EDP) in AAA attract neutrophils to the AAA site (171). 
Coagulation factors, such as factor XIII, are degraded by elastase, while 
factors VII, VIII, IX, and XII are inactivated by elastase (172, 173). Normally, tissues 
are protected by inhibitors of this protease. The major inhibitor for NE is α-1-
antitrypsin, which is a serine protease inhibitor generated by the liver and released 
into the blood in high amounts. The other inhibitor of elastase is called elafin, which is 
produced by epithelial cells in lung and skin. Inflammatory processes and 
involvement of matrix metalloproteinases can block the activity of α-1-antitrypsin, 
despite its saturating concentrations in the blood. 
Cigarette smoke and its major component, nicotine (141), increase NE activity 
and at the same time impair the ability of α-1-antitrypsin to inhibit elastin. These two 
effects lead to more activity of NE (174). Impairment in the ability of α-1-antitrypsin to 
inhibit NE is mediated by oxidation of one amino acid in the active site of α-1-
antitrypsin, which makes its attachment to NE less effective (175). 
NE is capable of degrading fibrin in ILT (176). Fibrin, however, is degraded 
mostly by plasmin/mini-plasminogen, and the degradation products are different 
arrangements of 2 core fibrin fragments, fragment D and E. DD, DDE and E, with the 
major product being, DD also called D-Dimer. Plasma levels of D-dimer have been 
showed to correlate with growth of AAA (177). NE degrades fibrin into a peptide, 
called the NE degraded product (XDP), that differs from D-dimer by a few amino 
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acids and can be separately assayed (178). NE is capable of cleaving plasminogen 
to “dess Kringle 1-4” also called mini-plasminogen. Mini-plasminogen activated to 
mini-plasmin in a faster rate than the activation of plasminogen to plasmin. Mini-
plasminogen is resistant to inhibition compared to plasminogen and also more 
effective at degrading fibrin. Therefore, NE can degrade fibrin directly or indirectly by 
activating mini-plasminogen (179). 
Consequently neutrophils leucocytes associated with thrombi contribute to 
fibrinolysis (176). 
Several fibrinolysis and coagulation factors, such as thrombin-antithrombin III 
complex (TAT) and fibrin/fibrinogen-degraded products (FDP) have shown to 
correlate with size of AAA. Another component of fibrinolysis investigated in AAA is 
plasminogen activator inhibitor type 1 (PAI-1), which is an inhibitor of fibrinolysis. 
PAI-1 acts by inhibiting tissue plasminogen activator (tPA) and urokinase 
plasminogen activator (uPA), which are activators of plasminogen (180). It has been 
shown that NE is capable of inactivating PAI-1, which is yet another mechanism to 
enhance fibrinolysis. This degradation will facilitate bleeding into the ILT and 
increases the risk of rupture. 
 
5.4.2  Metalloproteinases and their inhibition by TIMPs 
Matrix metalloproteinases (MMPs) are proteins with a zinc-binding motif in 
their catalytic domain and are responsible for degrading collagens, gelatins, and 
elastin in the aortic wall of AAA. These proteases are involved in several biological 
events, such as reproduction, development, morphogenesis, and wound healing. 
They also play a role in protection against bacterial invasion (181). 
Metalloproteinases are zymogens and need cleavage of their pro domain to be 
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activated. Plasmin, a protein involved in fibrinolysis, is considered to be an activator 
of metalloproteinases (182). 
The major collagenases are MMP1, MMP8 and MMP13. These proteases are 
able to degrade triple helical domain of collagens at physiological pH. The major 
gelatinases are MMP2 and MMP9 and are capable of digesting denatured collagen. 
Tissue inhibitors of metalloproteases (TIMPs) have many biological roles, 
such as modulation of cell proliferation, anti-angiogenesis, anti- and pro-apoptosis, 
signaling, and cell migration (183), but the most studied function of TIMPs is the 
inhibition of metalloproteases. TIMPs 1-4 inhibit MMPs (181, 183). In one study, Lipp 
et al showed that TIMPs 1-3 in human AAA are suppressed compared to control 
aorta (184). The elastase-induced model of AAA produces a more severe phenotype 
in mice lacking expression of TIMP1 (185). Because TIMPs have anti-angiogenic 
properties (183), a lack of TIMPs in AAA tissue could promote angiogenesis. In a 
recent study, the thickness of the ILT was correlated with the concentration of TIMP1 
and active MMP9 in the aortic wall of AAA and that showed to be independent of 
other variables, such as statin use, age, and gender (185). 
The rupture site of AAA shows an increase in the concentrations of MMPs, 
such as MMP8 and MMP9 (187). In the elastase-induced model of AAA, mice 
deficient in MMP9 (Mmp9-/-) showed attenuation of AAA progression compared to 
wild-type Mmp+/+ controls. 
MMP9 activity is preserved when the protein binds neutrophil gelatinase-
associated lipocalin (N-GAL), because degradation of MMP9 is halted (188).Thus, N-
GAL enables MMP9 to continue to degrade collagen and elastin of AAA wall. 
ADAMs (A Disintegrin And Metalloprotease) are a group of proteases 
belonging to the metalloproteinase family, but several members of this group have a 
trans-membrane domain. Similar to other MMPs, ADAMs also contain a zinc-binding 
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domain in their active site. ADAMs are produced as zymogens and are activated in 
the cytoplasm before they are transported to the cell membrane, where they are 
anchored in the phospholipid bilayer by their trans-membrane domain (189). 
ADAM10 and ADAM17, which are studied in this thesis, cleave other 
membrane proteins, causing them to become activated or shed. Tumor necrosis 
factor alpha (TNFα) is one of the proteins activated by ADAMs that possess TNFα 
converting enzyme (TACE) activity, especially ADAM10 and ADAM17 (190). 
TNFa is a cytokine produced by activated macrophages and other cells. TNFa 
has a major role in the induction of inflammation and apoptosis (191). In the elastase-
induced model of AAA, mice lacking receptors for TNFa showed only limited 
development of AAA. TNFa, together with c-JNK N-terminal kinase JNK and NonO, 
(a 54 kDa nuclear RNA and DNA binding protein) inhibit the expression of prolyl-4 
hydroxylase (P4H), an enzyme required for synthesis of all collagens. Inhibition of 
P4H decreases collagen synthesis. TNFa and JNK also participate in the induction of 
genes, such as MMPs, that are responsible for matrix degradation  
It has been shown that ADAM17 (TACE) is up-regulated in the media and 
adventitia of the aneurysmal wall and that TNFa has a role in the pathogenesis of 
AAA (192). 
In addition to TNFa, the substrates for ADAMs include other vessel-wall 
proteins, such as syndecan -1 and -4, collagen type XVII, ICAM-1 and VCAM-1 
(193). Inhibitors of ADAM10 and ADAM17 include TIMPs 1-3   
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5.4.3 Cathepsins, Tryptase, Chymase, Granzyme B 
Other proteases that may play a role in the pathogenesis of AAA include 
cathepsins, tryptase, chymase, and Granzyme B. 
Cathepsins are cysteine, aspartyl or serine proteases that are active mostly in 
the lysosomes of cells involved in protein degradation. Twelve members of this family 
have been identified. They are active at low pH and have been indicated to have a 
role in elastolysis (194). 
In the elastase-induced model of AAA, mice deficient in cathepsin C (195) 
and L were resistant to developing aneurysms. 
Active cathepsin D and cathepsin L were found in the aneurysmal wall, and 
their concentrations were higher in AAA than in healthy control aorta. The activity of 
these proteases was shown to be higher in the ILT of AAA compared to an in-vitro 
produced blood clot from donors (197). Shortly after, the same group showed that 
activity of other cathepsins, namely, cathepsin A, cathepsin D, and cathepsin G, were 
higher in the ILT than in the blood clot while activity of catehpsin B, cathepsin C and 
cathepsin E was only slightly higher in the ILT of AAA patients compared to the blood 
clot (196). In addition, plasma of AAA patients was reported to contain elevated 
concentrations and activity of cathepsin D compared to control plasma (196). 
Another group showed that cathepsin originates from neutrophils and mast 
cells in AAA tissue (151). Mast cells also release tryptase and chymase during 
degranulation and are abundant in AAA. Both tryptase and chymase are involved in  
the activation of MMPs and cause apoptosis of smooth muscle cells in AAA . 
Granzyme B is a protease produced by cytotoxic T-lymphocytes involved in 
antitumor and antiviral activities of host immune defense, and their presence in AAA 
tissue has been demonstrated (198). 
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Chapter VI   
Our Study   
 
6.1 Background  
Rupture is an acute and life-threatening complication of abdominal aortic 
aneurysm (AAA). Its risk increases with aortic diameter; however, it is not negligible 
in relatively smaller AAAs (sizing: 4.0- 5.5 cm) in which its incidence ranges from 1% 
to 5 % per year. Thus, although the time of surgery is currently delayed until the 
aneurysm reaches 5.5 cm in diameter, (199) predicting AAA rupture risk remains a 
major issue in vascular medicine. On one side, this task implies a model, that is, a 
complete comprehension of the factors contributing to the precipitation of this 
syndrome, of their interplay, and temporal sequence. On the other side, it also asks 
for the availability of methods able to describe the presence of these same factors 
and their activation in each single patient at risk. According to these considerations, 
several authors investigated the role of inflammation because these pathways 
underlie many of acute complications of atherosclerotic disorders and can worsen the 
effect of biomechanical forces acting on the diseased aorta. Actually, AAA 
development in experimental models is paralleled by the appearance of inflammatory 
infiltrates (37, 200) whose release of matrix metalloproteinases (MMPs) and 
proinflammatory cytokines ultimately results in an accelerated proteolysis of elastin 
and collagen of aortic wall. In recent years, this inflammatory paradigm of AAA 
rupture has been extended to the clinical arena, as the increased availability of 
positron emission tomography/ computed tomography (PET/CT) imaging systems 
permit the detection of focal arterial inflammation as areas of increased 18F-
fluorodeoxyglucose (FDG) (92, 201) caused by the elevated insulin independent 
glucose consumption of infiltrating leukocytes (203). Actually, the high content of 
activated macrophages justifies the use of PET/CT imaging to identify vulnerable 
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plaques in a variety of acute complications of atherosclerosis (204). However, the 
pathologic features of AAA seem relatively unsuitable for this purpose, as the 
progression of aortic dilation is paralleled by a reduction in cell density and thus by a 
local reduction in the elements able to trap FDG (205). This consideration implies 
that PET/ CT might represent a relatively inaccurate method to identify the 
inflammatory activation in asymptomatic patients with AAA characterized by even a 
relatively low-diameter dilatation.  
Conflicting results have been reported about the clinical value of 
fluorodeoxyglucose (FDG) imaging in predicting the risk of rupture of abdominal 
aortic aneurysm (AAA).  
Actually, pathological evidence suggests that the progressive increase in 
aneurysmal diameter is parallelled by a reduction in cell density that might explain 
the inverse correlation between AAA size and FDG uptake with the possible 
confounding effect of nonspecific fluoride binding onto calcified arterial segments 
(206). 
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6.2 Objectives 
In the present study, we planned to verify the prevalence of visible FDG 
uptake in aneurysmal walls, adopting a case control approach. To identify the 
possible role of this technique in the clinical setting, selection criteria were focused 
on those patients in whom the question about risk of rupture represents the main 
clinical factor able to identify surgical correction. Accordingly, patients with symptoms 
as well as patients with any evidence of aortic wall fissuration were excluded a priori 
(objective 1).  
Moreover, we tested the hypothesis that with increasing AAA diameter cell 
density is too low to permit any visible FDG uptake. This limitation would particularly 
apply to asymptomatic patients bearing aortic dilatation with a size falling within a 
“grey zone” close to surgical indication but with uncertain therapeutic approach. For 
this purpose, we first tested the spatial agreement of radioactivity concentration with 
local cell density, type and mitotic activity by coregistering autoradiography with 
histological and immunohistochemical images. Then, to verify the specific nature of 
tracer binding, we tested the relationship between FDG uptake and glucose 
metabolism by modifying cell viability and biology via a preliminary freezing of 
aneurysmal samples (objective 2). 
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6.3 Methods Objective 1  
 
6.3.1 Patient Population 
This study included 40 males (mean age: 74 years, range: 59-93 years), consecutive, 
white Caucasian patients, with asymptomatic infrarenal AAA, selected by the 
outpatient clinic of Vascular and Endovascular Surgery Division of University Hospital 
“San Martino” Genoa Italy between January 2009 and 2010. All subjects were 
candidates to open surgical repair of AAA according to conventional morphological 
criteria: saccular aneurysm, aortic diameter ≥ 5 cm, or diameter increase >1 cm in 
the last 6 months (Table II).  
Table II. Indication to treatment of asymptomatic abdominal aortic aneurysm 
Type of indication  Patients (n) Mean diameter of aneurysms (cm) 
Saccular aneurysm  11 4.9 
Increase size of diameter 
(>1cm/6 months) 
 
19 
 
5 
Diameter >/= 5 cm  12 5.1 
Total  42 5 
 
Within the series of AAA with diameter <5 cm under observation during the 
study period, the subgroups of cases characterized by rapid expansion or saccular 
aneurysm n have been selected. The mean diameter of AAA was 4.9 cm (range: 4.8-
5.4 cm), as measured by CT scan. Exclusion criteria were the presence of 
congestive heart failure, impaired renal function (serum creatinine, >1.5 mg/dL), 
known intolerance to iodinated contrast media, or elevated blood glucose level (>130 
mg/dL).  
Of 40 patients, 26 underwent open repair of AAA, 9 received endovascular 
treatment, and 5 refused the surgery. All patients provided written informed consent. 
Patient demographic information included age, gender, smoking history 
(current, ex-smoker, no smoking), coronary heart disease, degree of carotid stenosis, 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:26:56 EEST - 137.108.70.13
 55 
 
hypertension, renal insufficiency, and diabetes mellitus. Cardiovascular medication 
was also recorded (statin, B-blocker, antiplatelet). All patients with coronary heart 
disease and renal failure were evaluated as reported by international guidelines. 
These patients were considered as having moderate surgical risk and good life 
expectancy. 
The following were measured before surgery: plasma glucose, triglycerides, 
high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, 
uric acid, C-reactive protein, fibrinogen, D-dimer, N-terminal pro-brain natriuretic 
peptide (NT-proBNP), white blood cell count, lymphocyte count, monocyte count, and 
neutrophil count. 
Control Subjects: Data were compared with findings obtained in 44 age-
matched controls subjects (mean age: 71 years, range: 59-85 years, 24 males, 20 
females) who were selected according to a case control criterion among a population 
of patients without any clinical evidence of atherosclerotic disease who were 
submitted to PET/CT scan as a part of the workup of characterization of neoplastic 
disease. Patients previously submitted to chemotherapy or radiotherapy, patients 
with aortic dilatation, as well as patients with suspected autoimmune disease were 
excluded. 
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6.3.2 PET/CT Acquisition 
After a minimum of 6-hour fasting, a dose of 4.8 to 5.2 MBq of FDG per 
kilogram body weight was injected through a peripheral vein catheter. The patient 
was placed in a quiet room and instructed not to move. Data acquisition started ≥ 60 
minutes after intravenous tracer administration. Both patients and controls underwent 
simultaneous FDG-PET and CT imaging from the skull base to the femoral neck by 
using an integrated PET/CT scanner (Hirez; Siemens Medical Solutions, Knoxville 
TN). PET raw data were reconstructed by means of ordered subset expectation 
maximization, and attenuation correction was performed using the CT raw data 
(ordered subset expectation maximization). 
The entire CT dataset was fused with the three-dimensional PET images 
using an integrated software interface (Syngo Image Fusion; Siemens Erlangen, 
Germany) to create anatomical images superimposed with FDG uptake in the arterial 
wall. 
 
6.3.2a Image Analysis 
To take account of presence and pathophysiological meaning of arterial hot 
spots as well as diffuse vascular wall hypermetabolism, both qualitative (visual) and 
quantitative (region of interest [ROI]- based) analyses were performed on PET/CT 
images. 
 
6.3.2b Visual Analysis 
Two independent readers carefully inspected images by performing a 
complete slice-by-slice analysis. Visual analysis aimed to search for the presence of 
hot spots of degree adequate to identify the aneurysmal arterial wall as well as all 
other vascular segments included in the PET/CT study. 
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6.3.2c Quantitative Analysis 
To better characterize the metabolic pattern of the whole vascular tree and 
the peculiar aspects of AAA, a quantitative analysis was also performed. To this 
purpose, volumetric ROIs were placed on the anatomic CT images to identify aortic 
segments (ascending, arch, descending, and abdominal aorta), bilateral subclavian, 
common carotid, and iliac arteries (Figure 6.1- 6.2). 
 
 
Figure 6.1 Image analysis on transaxial fused positron emission 
tomography/computed tomography (PET/CT) (coronal and transversal sections) of 
aortic segments: Circular regions of interest (ROIs) were drawn around different 
aortic segments: ascending (panel A), arch (panel B), and descending (panel C) 
aorta. PET image provided mean and maximum standardized uptake values (SUVs) 
within defined ROIs. 18F-fluorodeoxyglucose (FDG) uptake within each ROI was 
finally divided by circulating FDG (blood-pool ROI). 
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Figure 6.2 Example of image analysis on transaxial fused PET/CT (coronal 
and transversal sections) of right common carotid artery (panel A) and left 
subclavian artery (panel B). PET image provides mean and maximum SUVs within 
defined ROI. FDG uptake within each ROI was finally divided by circulating FDG 
(blood-pool ROI). 
 
 
In all patients with AAA, a further ROI was drawn over the aneurysmal arterial 
walls (Figure 6.3B). Finally, two ROIs were drawn within the liver and the left 
ventricular chamber to estimate liver uptake and tracer concentration in the arterial 
blood, respectively (Fig. 6.4). 
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Figure 6.3 Image analysis on transaxial fused PET/CT (coronal and 
transversal sections) of abdominal aorta (panel A), abdominal aortic aneurism (panel 
B), and iliac arteries (panel C). PET image provides mean and maximum SUVs 
within defined ROI. FDG uptake within each ROI was finally divided by circulating 
FDG (blood-pool ROI). 
 
 
Figure 6.4 Liver and Blood-pool ROIs 
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FDG uptake was thus quantified by calculating the mean and maximal 
standardized uptake values (SUVs) within each ROI. Finally, these values were 
normalized for the blood-pool SUV, thus obtaining a target-to-background ratio and 
avoiding the confounding effect of circulating FDG. Bilateral measurements were 
averaged. 
 
6.3.2d Calcium Load Evaluation 
Total calcium load (ACL) was also estimated in the same arterial segments. 
To this purpose, two independent observers, blinded to the patient status, were 
asked to grade calcium density according to a semiquantitative five point scale based 
on percent calcification of the arterial ring documented in the transaxial views: (0= no 
calcific deposits, 1= 0-25%, 2= 25%-50%, 3= 50%-75%, and 4= 75%-100%). 
 
6.3.2e Statistical Analysis 
Intergroup differences in arterial mean and maximum SUVs were tested in 
each vascular segment by using Student t test for unpaired data and Bonferroni 
correction. Linear regression analysis was performed using the least squares method 
to assess the relationships between arterial wall metabolism in each artery and ACL 
or aneurysm maximum diameter. P < 0.05 was considered significant. 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:26:56 EEST - 137.108.70.13
 61 
 
6.4 Methods objective 2 
 
6.4.1 Patients Population  
The study included 12 consecutive patients (10 men, 2 women, mean age 
73±5, range 65–85 years) with asymptomatic AAA selected by the outpatient clinic of 
the Vascular and Endovascular Surgery Division of University Hospital “San Martino” 
Genoa Italy.  All subjects were candidates for open surgical repair of AAA according 
to the evidence of diameter increase >10 mm in the last 6 months. The maximum 
anteroposterior aneurysm diameter was measured by CT and ranged from 45 to 53 
mm (mean diameter 48±3.5 mm) at the time of surgery. The main exclusion criteria 
included the presence of congestive heart failure, impaired renal function (serum 
creatinine >1.5 mg/dl), known intolerance to CT-iodinated contrast media or elevated 
blood glucose level (>130 mg/dl), significant concomitant diseases such as cancer, 
infections and, finally, autoimmune disorders. 
Imaging data were compared with findings obtained in 12 age- and sex-
matched subjects who were selected according to a case-control criterion among a 
population without cardiovascular risk factors or clinical evidence of cardiovascular 
disorders. All of these patients were submitted to PET/CT scan in the diagnostic 
workup of a suspected neoplastic disease. Patients previously submitted to either 
chemotherapy or radiotherapy, patients with aortic dilatation as well as patients with 
suspected autoimmune disease were excluded from the study. All patients signed the 
informed consent module to participate in the study that was approved by the local 
Ethics Committee. 
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6.4.2 Biochemical assays 
Fasting blood samples were collected from all study subjects in the morning 
after resting in the supine position for 20 min during their outpatient clinical 
appointment. 
Plasma glucose, lipid and renal profile, total protein, serum fibrinogen, C-
reactive protein (CRP) and N-terminal probrain natriuretic peptide (NT-proBNP) were 
assessed using standard techniques. Similarly, leukocyte and monocyte counts were 
measured using automated cell counters. 
 
6.4.3 PET/CT acquisition 
After a 12-h fast, serum glucose level was measured before the intravenous 
injection of 4.8–5.2 MBq of FDG per kilogram of body weight. All of these procedures 
were performed 4–10 days before surgery, with the patient recumbent in a supine 
position in a quiet room and instructed not to move. FDG PET imaging, from the skull 
base to the femoral neck, started 60–90 min after tracer injection and was performed 
using an integrated PET/CT scanner characterized by a PET spatial resolution of 4 
mm full-width at half-maximum (Hi-REZ, Siemens Medical Solutions, Knoxville, TN, 
USA). 
CT aortic angiography was performed within 1 week from the FDG PET study 
using the same 16-slice CT scanner. Patients were placed in a supine position, and 
topograms in the anteroposterior view were obtained from the diaphragm to the 
pelvis. Intravenous contrast medium was injected into an antecubital vein, using an 
automatic injection system via a 20-gauge cannula. Synchronization between the 
passage of contrast and baseline arterial phase was conducted in real time using an 
automatic fire detection system on the upper abdominal aorta (Bolus Tracking, 
SiemensMedical Solutions, Erlangen, Germany). The control sequence was 
activated 10 s after the start of contrast injection and implied the acquisition of one 
image every second. The start of the study was triggered automatically when the 
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intensity level of contrast reached 180 HU, within a region of interest (ROI) placed on 
the abdominal aorta. In all cases, the craniocaudal direction was used. 
 
6.4.3a In vivo image analysis 
PET raw data were reconstructed by means of ordered subset expectation 
maximization (OSEM) and attenuation correction was performed using the CT raw 
data. The entire CT data set was fused with the three-dimensional PET images using 
an integrated software interface (Syngo Image Fusion, Siemens Medical Solutions, 
Erlangen, Germany) to create anatomical images superimposed with FDG uptake in 
the investigated body districts. 
Volumetric regions of interest (VROIs) were placed on the anatomical CT 
images to identify four aortic segments (ascending, arch, descending and abdominal 
aorta), common carotid arteries and iliac arteries. In the case of bilateral branches, 
the mean value was considered. Two further VROIs were drawn in the liver and in 
the left ventricular chamber using the PET image to estimate liver uptake and arterial 
tracer concentration, respectively. Finally, in all patients with AAA, an additional 
VROI was drawn over the aneurysmal arterial walls. 
FDG uptake was quantified by the maximum standardized uptake value 
(SUV) within each VROI according to the recently published guidelines (207). To 
account for the contribution of blood FDG activity, all SUVs were divided by the 
corresponding value in the blood pool as proposed by Rudd et al. (208, 209). In no 
case was correction for partial volume effect attempted due to the absence of clearly 
visible areas of focal uptake within the analysed vascular segments (210). 
The degree of arterial calcification was measured from the takeoff of renal 
arteries to bifurcation of aorta into common iliac arteries. For this purpose, we used 
dedicated software (OsiriX) providing Agatston scores whose values were adjusted 
to account for slice width as previously published by Ellison et al. (211). In the 
aneurysmal walls, arterial calcium load was estimated according to the 
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semiquantitative method proposed by Siegel et al. (212). For this purpose, two 
independent observers, blinded to the patient status, were asked to grade calcium 
density according to a semiquantitative 5-point scale based on per cent calcification 
of the arterial ring documented in the transaxial views: (0=no calcific deposits, 1=0–
25%, 2=25–50%, 3=50–75% and 4=75–100%). 
Autoradiographic analysis of abdominal aneurysmal artery samples At the 
time of the surgical repair, the biodistribution of FDG within the aortic tissue was 
studied with digital autoradiography. Immediately after harvesting, the aneurysmal 
abdominal aorta was taken to the pathology lab of our hospital. The specimen was 
dissected, blood was washed with saline and the surrounding connective tissue and 
fat were removed. The AAA sample was then divided into three sequential blocks, 
from A to C. Blocks A and C were used for autoradiography, while block B was 
submitted to immunohistochemistry. The thickness of each block ranged from 3 to 5 
mm for a weight of 150–450 mg. 
Block A was frozen in isopentane chilled with dry ice for sectioning with a 
cryomicrotome, according to the procedure described by Laitinen et al. (206). 
Starting from the cutting border with block B, a minimum of three sequential sections 
were cut at −15°C and thaw-mounted onto microscope slides. Slice thickness was 
set at 5 μm to optimize image spatial resolution. The sections were then warmed to 
room temperature, incubated in saline for 20 min and, thereafter, immersed in 20 ml 
of saline containing 2–3 MBq/ml of FDG for 30 min. Thus, the slices were washed 
twice with ice-cold saline, rinsed in distilled water and air-dried (with a hair dryer for 
10 min). 
By contrast, the whole fresh block C was first incubated in the same tracer 
solution, for the same time and under the same experimental conditions used for the 
sections from block A. Thus, the specimen was washed, dried and then frozen in 
isopentane chilled with dry ice for sectioning with the cryomicrotome with the same 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:26:56 EEST - 137.108.70.13
 65 
 
procedure used for block A, again obtaining a minimum of three sequential sections, 
5 μm thick, starting from the cutting border with block B. 
Thereafter, all slides were exposed to an imaging plate (Cyclone, PerkinElmer 
Analysis Facilities) that provides an image resolution of 50 μm. Different times of 
exposure were sequentially utilized in all experiments: 2, 5, 15, 30 and 60 min. At the 
end of the procedure, all aortic sections were stained using the haematoxylin and 
eosin technique.  
 
6.4.3b  Autoradiographic image analysis 
Plates were scanned and images were analysed for count densities 
(photostimulated luminescence per unit area, PSL/mm2) with a dedicated image 
analysis software (OsiriX). For this purpose, a minimum of four ROIs were manually 
drawn in each image to identify hot and cold areas, respectively. Each region was 
thus saved to be exported for blind histological analysis. 
For freshly incubated specimens, an exposure to the imaging plate longer 
than 5 min systematically prevented the analysis of FDG distribution due to 
saturation effect. On the contrary, for previously frozen slices, an exposure time 
shorter than 30 min consistently prevented an adequate analysis due to poor image 
statistics. 
FDG uptake in samples incubated before or after freezing was estimated by 
comparing the number of PSD (counts) normalized for the different acquisition times 
(5 vs 30 min) and the consequent effect of 18F physical decay, according to the 
conventional formulations. 
 
6.4.3c  Histology 
The central block B was fixed in 10% formalin solution and embedded in 
paraffin to optimize immunohistochemical analysis. Thereafter, two series of five—5 
μm thick— paraffin sections were obtained, starting from both cutting borders facing 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:26:56 EEST - 137.108.70.13
 66 
 
toward either block A or block C. This procedure ensured that each autoradiography, 
regardless of its provenience, had a direct immunohistochemical counterpart 
obtained in the adjacent tissue. 
Starting from each cutting border, block B sections were always stained, 
according to the same order, to allow the sequential analysis of the following 
variables: (1) tissue structure, (2) cells under any phase of active cell cycle, (3) 
leukocyte nature of cellular infiltrates and, finally, (4) T and B lymphocytes. 
No histological analysis was performed on autoradiography slices to avoid the 
relative loss in image quality affecting previously frozen sections. 
Immunohistochemistry evaluation was performed using a panel with CD3 (Ventana), 
CD20 (Ventana) and Ki-67/MIB-1 (Dako) antibodies, in a ready-touse formulation, on 
the paraffin-embedded and formalin-fixed slides. The standard avidin-biotin complex 
technique was employed for all immunostains; antibodies were optimized for use an 
automated slide stainer in combination with Ventana detection kits. Heat 
pretreatment (microwave) and endogenous biotin blocking were performed for all of 
the abovementioned antibodies. Finally, all slides were counterstained with 
haematoxylin for 4 min. 
A report was completed by two experienced pathologists, who described the 
specimens on a standard reporting form that included degree of atherosclerosis 
(graded 0–3) (213), plaque and vessel calcification as well as degree of medial and 
adventitial inflammation (density of inflammatory cells). For the coregistration study, 
pathology readers were blinded to the results of autoradiography and, in particular, 
were left unaware of ROI nature (hot or cold). ROI borders, saved in TIFF format, 
were reported on all of the histological images formatted in the same matrix. 
 
6.4.3d  Statistical analysis 
Intergroup differences in maximal arterial SUV were tested in each vascular 
segment using Student’s t test for unpaired data. Intersegment variability in arterial 
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SUV was tested in each patient using the t test for paired data and Bonferroni 
correction. Linear regression analysis was performed using the least-squares 
method. A p value <0.05 was considered significant. 
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6.5 Results objective 1 
 
6.5.1 Clinical Data 
The main clinical and metabolic characteristics of the study group are 
reported in Tables III and IV, respectively. 
Surgical intervention was successfully completed in 35 patients, and no 
complication occurred in the postoperative period. 
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Table III. Clinical characteristics of patients with asymptomatic abdominal 
aortic aneurysm (n =42) 
Patients Characteristics  
Mean age (years)  74.0 
Sex (M/F)  40/0 
Mean diameter (cm) 4.9 cm 4,9 cm 
Hypertension  35/5 
Systolic blood pressure (mm Hg)  144 ± 18 
Diastolic blood pressure (mm Hg)  83 ± 9 
Diabetes mellitus (yes/no)a  3/37 
Coronary heart disease (yes/no)  10/30 
Degree of carotid stenosis (right or left)b 
<50% (n)  
>50% (n)  
 
9 
2 
Degree of carotid stenosis (bilateral)b 
<50% (n)  
>50 % (n)  
 
20 
8 
Renal insufficiency (yes/no)c  5/35 
Body mass index (kg/m2)  26.1 ± 3.2 
Antiplatelet therapy (yes/no)  18/22 
B-blocker (yes/no)  11/29 
Statin (yes/no)  20/20 
a Blood glucose level >130 mg/dL. 
b Serum creatinine level <1.5 mg/dL. 
c Degree of stenosis measured by North American Symptomatic Carotid 
Endarterectomy Trial. 
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Table IV. Metabolic characteristics of patients with asymptomatic abdominal 
aortic aneurysm (n = 42) 
Circulating serum markers  Value ± SD 
CRP (mg/dL)  8.8 ± 4.2 
Fibrinogen (g/L)  412.1 ± 117.1 
D-dimer (mg/L)  412.1 ± 225.5 
LDL cholesterol (mg/dL)  138 ± 49.6 
HDL cholesterol (mg/dL)  50.1 ± 13.6 
Total cholesterol (mg/dL)  210 ± 55.1 
Triglycerides (mg/dL)  230 ± 52.5 
Uric acid (mg/dL)  6.17 ± 1.94 
NT-proBNP  603 ± 204 
White blood cell count (x109/L)  7,319 ± 2,225 
Neutrophil count (x109/L) 5,230 ± 1,751 
Monocyte count (x109/L) 467 ± 150 
Lymphocyte count (x109/L) 1,565 ± 367 
CRP, C-reactive protein; LDL, low-density lipoprotein; HDL, high-density 
lipoprotein; NT-proBNP, N-terminal pro-brain natriuretic peptide. 
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6.5.2 PET/CT Evaluation of AAA 
On visual inspection, no patient showed an increased focal uptake of degree 
adequate to identify the aneurysmal arterial wall. Main descriptors of systemic FDG 
kinetics were similar in the patient and control groups (liver average SUV: 2.3 ± 0.5 
vs. 2.2 ± 0.4, P = no significant; the blood-pool average SUV: 2.1 ± 0.8 vs. 2 ± 0.6,   
P = no significant). Arterial wall metabolism was similar in all aortic segments and in 
the subclavian arteries in the two groups, although both common carotid arteries and 
iliac branches displayed a significantly higher SUV in patients compared with controls 
(carotid arteries: patients, 0.79 ± 0.2; controls, 0.65 ± 0.2; P < 0.02 and iliac arteries: 
patients, 0.80 ± 0.2; controls, 0.67 ± 0.2; P < 0.05. See Figure 6.5 for further details). 
 
 
Figure 6.5 Wall metabolic activity (mean SUV/blood pressure) in the analyzed 
vascular districts. Metabolic activity in the aneurysmal aortic segment was lower with 
respect to both nonaneurysmal aorta of patient group (P < 0.001) and the 
corresponding arterial segments of control subjects (P < 0.01). On the contrary, both 
common carotid arteries (*P < 0.02) and iliac branches (*P < 0.05.) displayed a 
significantly higher wall metabolic activity in patients compared with controls. 
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On the contrary, average metabolic activity in the aneurysmal aortic segment 
was even lower with respect to both the adjacent -non aneurysmal- aorta of patient 
group and the corresponding arterial segments of control subjects (0.7 ± 0.2, 1 ± 0.3, 
and 0.9 ± 0.3, respectively; P < 0.001 versus non aneurysmal segment of the same 
patient and P < 0.01 versus the same segment of control subjects Figure 6.5). 
Analysis of maximum SUV replicated the same results with lower values in 
aneurysmal wall compared with normal abdominal aorta of patients and controls (0.9 
± 0.3, 1.1 ± 0.3, and 1 ± 0.2, respectively; P < 0.01). Again, uptake by carotid arteries 
was higher in patients with respect to controls (1 ± 0.2 vs. 0.78 ± 0.2, P < 0.01). 
Finally, no correlation was observed between FDG uptake in aneurysmal 
walls and AAA diameter. Atherosclerotic involvement was documented in AAA, as 
these patients showed significantly higher values of ACL than controls in ascending 
aorta and subclavian and iliac arteries (0.8 ± 0.4 vs. 0.2 ± 0.1 for ascending aorta, 
0.5 ± 0.3 vs. 0.3 ± 0.1 for subclavian arteries, and 2.1 ± 1.2 vs. 1.3 ± 1 for iliac 
arteries; P < 0.01 in all cases). 
Finally, only in AAA patient group, a significant correlation was present 
between values of ACL in iliac arteries (Figure 6.6) and abdominal aorta (Figure 6.7) 
and wall metabolic activity in the same arteries (P < 0.05). 
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Figure 6.6 Inverse correlations between metabolic activity in iliac artery wall 
and calcium load. 
 
 
Figure 6.7 Inverse correlations between metabolic activity in abdominal aortic 
aneurysm wall and calcium load. 
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6.6 Results Objective 2 
 
6.6.1 Clinical data 
The main clinical and metabolic characteristics were similar in patients and 
controls as reported in Tables V and VI, respectively. Surgical intervention was 
successfully completed in all patients and no complication in the postoperative period 
occurred. An AAA example is reported in Figure 6.8, where the image fusion of CT 
angiography and FDG PET clearly shows, on one side, the vascular dilatation 
associated with the presence of calcium load and, on the other, the low metabolic 
activity of the aneurysmal walls. 
 
Table V Demographics and treatment of study subjects 
 AAA patients (n=12) Controls (n=12) 
Age (years)  73±5 73±4 
M/F  11/1 11/1 
Body mass index (kg/m2)  24.5±0.4 22.2±0.4 
History of smoking (%)  10/12 (83%) 7/12 (58%) 
Hypertension (%)  11/12 (92%) 8/12 (67%) 
Hypercholesterolaemia (%)  8/12 (67%) – 
ACE 1 or AT1 inhibitors (%)  10/12 (83%) 6/12 (50%) 
β-Blockers (%)  2/12 (17%) 1/12 (8%) 
Aspirin or ticlopidine (%)  11/12 (92%) 5/12 (42%) 
Age (years)  73±5 73±4 
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Table VI Laboratory tests of study patients 
 AAA patients (n=12) Controls (n=12) 
Blood glucose (mg/dl)  96.2±9.0 88±12 
Total serum cholesterol (mg/dl)  176.4±14.6 – 
Triglycerides (mg/dl)  84±12 – 
Uric acid (mg/dl−1)  5.4±0.4 – 
Creatinine (mg/dl−1)  1.02±0.11 0.96±0.14 
Total protein (g/dl−1)  7.8±0.2 – 
Serum fibrinogen (mg/dl−1)  327±50 – 
CRP (mg/l−1)  6.4±4.1 – 
NT-proBNP (pg/ml)  118±57.2 – 
White blood cell count (mm−3)  6,943±411 6,712±582 
Neutrophil count (mm−3)  4,712±264 4,221±291 
Monocyte count (mm−3)  452±71 411±62 
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3D PET/CT     Transaxial plane    3D CT angio 
  
                              A       B 
Figure 6.8 A: display 3-D 3D PET/CT Transaxial plane 3D CT angio 
reconstructions of PET/CT data and document the absence of any visible FDG 
uptake in the abdominal aortic region. CT transaxial plane (bottom, centre panel) 
displays the presence of an aortic aneurysm that is partially occupied by thrombotic 
material as documented by contrast CT angiography as well as by the absence of 
any visible FDG uptake at PET/CT coregistration. B: display the 3-D reconstructions 
of CT aortic angiography showing the aneurysmal portion as indicated by the green 
arrows 
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6.6.2 PET/CT evaluation of AAA 
The main descriptors of systemic FDG kinetics did not differ in the two 
populations. In fact, the average SUV was similar in patients and in controls both in 
liver (2.2±0.4 vs 2.1±0.5, respectively, p=NS) and in left ventricular blood (2.0±0.5 vs 
2.1±0.6, respectively, p=NS). As shown in Figure 7.2, no differences were observed 
in glucose metabolism in all non-diseased segments of aorta, common carotid 
arteries and iliac branches in the two groups. On the contrary, aneurysmal FDG 
uptake was significantly lower with respect to the corresponding arterial regions of 
control subjects (0.91±0.16 vs 1.54±0.39, respectively, p<0.01, Figure 6.9). 
Compared to control subjects, AAA patients showed no significant differences in 
calcium load (Figure 6.10) both in the whole infrarenal abdominal aorta (modified 
Agatston score: 3,845±2,000 vs 3,595±1,461, respectively, p=NS) and in the 
aneurysmal segment (semiquantitative scoring system: 2.9±1.2 vs 2.4±1.1, 
respectively, p=NS). 
Autoradiographic features of aortic aneurysm Independently of sample 
processing protocol, overall FDG distribution was largely heterogeneous with spots of 
clearly visible radioactivity surrounded by large areas characterized by low tracer 
content. Thrombi, when present, were always characterized by the absence of any 
visible radioactivity. 
The different processing protocols resulted in marked differences in glucose 
metabolism. Despite the fact that the two samples were incubated with the same 
tracer solution for an identical incubation time, the history of recent transient freezing 
decreased FDG uptake by almost 8 times in hot regions, i.e. from 30.5±8.7×103 
PSL/mm2 −1 min−1 (in freshly incubated samples) to 3.7±1.1×103 PSL/mm2 −1 min−1 (in 
previously frozen specimens, respectively, p<0.001). On the contrary, in cold areas 
tracer retention accounted for 3.5± 0.9×103 PSL/mm2 −1 min−1 vs 1.9±0.9×103 PSL/ 
mm2 −1 min−1 in fresh and previously frozen samples, respectively (p<0.001). 
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Thus, after the thermal shock, FDG uptake dramatically decreased by 87±5% 
within hot regions and by only 34± 35% in the cold ones (p<0.001). This differential 
effect obviously affected image quality by modifying the tracer distribution throughout 
the slice. In fact, the ratio between hot and cold areas was 9.2±2.7 in freshly 
incubated samples vs 2.2±0.7 in previously frozen ones (p<0.001). 
 
 
 
Figure 6.9 SUVs in the different arterial segments of patients and control 
subjects. The SUV was similar in all vascular segments in both groups (blue and red 
columns, respectively). Interestingly, FDG uptake was significantly lower in 
aneurysmal aortic segments with respect to controls subjects (green column). 
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Figure 6.10 Total calcium load (ACL) was similar in patients and in control 
subjects 
 
6.6.3 Histological correlates of FDG uptake in aortic aneurysm  
Aneurysm samples showed evidence of extensive atherosclerosis, graded 2–
3, in all biopsies with necrosis, lipid deposits and/or calcifications. Evidence of 
ulcerated plaque occurred in 10 of 12 cases within the anatomical piece. Adhesive 
thrombus within the histological specimen occurred in 6 of 12 patients. 
Haematoxylin and eosin staining of AAA specimens documented a loss of 
wall structure and a marked reduction in overall cell density. As expected, histological 
analysis documented a moderate inflammatory infiltration that encompassed the 
entire arterial wall although it was particularly evident in its outer layers. 
Representative examples of the extent of arterial wall inflammation are shown in 
Figure 6.11.  Immunohistochemistry showed that the majority of cells (>85%) in both 
adventitia and media were leukocytes as documented by CD45 staining in all cases, 
with a striking prevalence of CD3 and CD20 lymphocytes (>80%). On the contrary, 
granulocytes and macrophages were rarely found. Prevalence of cells in all phases 
of the active cycle was documented by Ki-67 expression and was 4.6±3%. There was 
no evidence of bacteria or other unusual findings in any biopsies. 
Arterial Calcium Load in Patients and in Control Subjects 
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Figure 6.11 Immunohistochemical and autoradiographic analysis of a 
pathological sample of aortic aneurysm, incubated with FDG before cryotome 
application. Top right panel displays the autoradiographic image obtained from a 
slice cut from block C at its border with block B. Left panels display the 
immunohistochemical images of three sequential slices obtained after fixation from 
block B at its cutting border with block C. At the right of each image, its coregistration 
with autoradiography is shown. Starting from the top each row displays T 
lymphocytes recognized by CD3 staining, B lymphocytes identified on the basis of 
CD20 positivity and cells actively synthesizing DNA documented by Ki-67 
expression. Despite the fact that these four images reflect the distribution of each 
marker in four sequential 5-μm thick slices, the close agreement between cell density 
and metabolic activity is evident on the right panels and is confirmed by the details 
shown for the first two rows. Original magnification ×200 
 
At coregistration analysis, the difference in tracer uptake was parallelled by an 
even more evident gap in cell density that was ten times higher in hot areas with 
respect to the cold ones without any differences between the two protocols (227±67 
vs 27±21 cells/mm2 in fresh samples, 212±70 vs 16±8 cells/mm2 in frozen samples, 
respectively, p<0.001). Moreover, all regions without any evidence of cells were 
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observed in cold ROIs. Similarly, the prevalence of cells actively synthesizing DNA, 
documented by their Ki-67 expression, was remarkably higher in hot than in cold 
regions both in freshly incubated samples (10±3% vs 1.8± 0.1%, respectively, 
p<0.01) and in slices incubated after freezing (8.3±3% vs 1.4±0.6%, p<0.01). 
Finally, as shown in Figures 6.12 and 6.13 a direct correlation was 
documented in each ROI between FDG concentration and density of both overall 
cells and cells in all phases of the active proliferation cycle. These correlations were 
more clearly evident for data obtained after incubation of fresh sample with respect to 
those provided by previously frozen slices. 
 
 
 
 
 
Figure 6.12 Tracer retention directly correlated with overall cell density and 
with prevalence of cells synthethizing DNA.  
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Figure 6.13 The metabolic nature of FDG uptake was confirmed by the 
selective effect of preliminary freezing that decreased tracer content by 90% in 
regions with high cell density and only by 34% in cold acellular areas 
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6.7 Discussion  
 
Objective 1 
The present study was designed to investigate whether imaging of the 
aneurysmal metabolism enables one to identify specific patterns among candidates 
to surgical abdominal repair of AAA. 
No patient of this series showed any visible focal tracer uptake of degree 
adequate to identify the AAA. Similarly, the metabolic activity in the aneurysmal aort ic 
segment was even lower compared with both the adjacent –nonaneurysmal- samples 
of the same patient and corresponding arterial segments of control subjects. By 
contrast, common carotid arteries and iliac branches displayed a significantly higher 
SUV in the AAA patients compared with controls. 
AAA is the end result of a multifactorial process culminating in irreversible 
pathological remodeling of the aortic wall connective tissue (214). Aneurysm rupture 
was historically considered to be a simple physical process that occurs when 
hemodynamic wall stress exceeds the tensile strength of the aortic wall (215). When 
the rate of collagen degradation exceeds the rate of collagen synthesis, the tensile 
strength of the aortic wall declines and the risk of rupture increases. Recently, this 
model has been integrated by the evidence that AAA expansion and rupture also 
reflect a multifactorial process involving biochemical, cellular, and proteolytic 
influences (40). Among these factors, a key role is played by the release of MMPs 
produced or activated by inflammatory cells, causing degradation of elastin and 
collagen in the aneurismal walls (216). Published findings seem to consistently 
indicate a great relevance for inflammatory wall digestion in both AAA progression 
and complication. Moreover, there is increasing evidence that MMPs and elastin 
degradation are implicated in the calcification process (217) that would reduce cell 
density in the aneurysmal wall. In keeping with these findings, the present study 
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reported an inverse correlation between arterial calcium load and wall metabolism in 
AAA. 
Recently, a great attention has been paid to the possible role of functional 
imaging with PET/CT in the definition of inflammatory infiltration of aneurysmal aorta. 
The rationale behind this use is the fact that glucose metabolism is relatively insulin 
independent in activated leucocytes. Accordingly, imaging of FDG uptake under 
fasting conditions characterized by low serum concentrations of insulin might be able 
to visualize focal inflammation of different structures, including diseased aorta. 
Reeps and coworkers reported slightly increased SUVs in 12 asymptomatic 
patients with relatively small aortic aneurysms (35 ± 6 mm) compared with 24 age-
matched control subjects (92). This finding has been partially confirmed by Truijers et 
al, who documented that the slight SUV increase displayed by AAA walls was mostly 
evident in subjects with relatively small aneurysms (218). 
Preliminary data in relatively larger aneurysms have been also provided. 
Kotze and colleagues reported an increased FDG uptake in 14 AAA patients in 
whom; however, the metabolic activity was not correlated with the recent growth rate 
(219). Finally, Sakalihasan et al. reported a positive FDG hot spot in the infrarenal 
aorta in 10 of 26 patients with an AAA ranging in size from 50 to 76 mm (90). 
The present findings only partially disagree with this recent literature and 
rather extend these previous observations by documenting, in a larger population of 
40 asymptomatic patients with AAA close to surgical indication, that a hot spot is an 
extremely rare finding in FDG imaging. On the contrary, tracer uptake in the diseased 
segment was even lower than that measured by the standard-method SUV in a 
population of subjects studied with a case control approach. 
Together with the previously cited studies, this observation seems to indicate 
that focal PET signs of increased metabolic activity might be more frequent in AAAs 
of relatively small size. On the contrary, the prevalence of positive FDG hot spots 
seems to decrease with the enlargement of the aortic lesion. This finding reflects 
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both pathophysiological and technical phenomena related to the well documented 
reduction in cell density in large AAAs. In fact, low cell density is usually associated 
with low FDG uptake values just because of the small number of elements able to 
use glucose and thus to retain the tracer. On the other hand, the dispersed nature of 
these cell islands results in a frequent artifact of nuclear medicine, called partial-
volume effect. This phenomenon implies a relevant underestimation of radioactivity 
concentration whenever the thickness of the source is less than twice the system 
spatial resolution. Because in most commercially available clinical systems, this 
parameter ranges from 4 to 7 mm, even large numbers of cells can be lost in PET 
imaging despite a high tracer uptake if they are dispersed in a large cellular matrix  
(220). 
In the present study, images were acquired 1 hour after injection as per 
conventional protocols for both oncological and non-oncological PET studies. 
Previous studies suggested that a delayed acquisition time (3 hours (89) and 90 
minutes (208) could be used for vascular inflammation imaging, as it would maximize 
the contrast between vascular wall and background (87). However, Menezes et al. 
(221) recently addressed this issue in 17 patients with atherosclerotic AAA and did 
not report any advantage compared with the most comfortable conventional timing. In 
the setting of our study, it seems extremely unlikely that waiting 2 hours more after 
injection would have resulted in a change of image pattern able to modify the main 
result of our experience, that is, visible FDG uptake is an extremely rare finding in 
patients with AAA close to surgical indication. 
The lack of scientific evidence regarding the optimal acquisition time is 
paralleled by wide and variable range of choices regarding image analyses. 
Published studies based their analysis upon several different methods, ranging from 
a simple visual revision of the images (90) to an arbitrary choice of an SUV max 
cutoff for defining a high level of FDG uptake (222) or to a quantitative analysis of 
SUV max without normalization for circulating FDG (218). 
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From 2007 to 2008 Rudd et al. (208, 209) published a method of whole vessel 
analysis and a list of recommendation for atherosclerosis inflammation imaging. This 
analysis consists of arterial FDG uptake measure obtained by drawing an ROI 
around the artery on every slice of the coregistered transaxial PET/CT images; then, 
mean and maximum SUVs are calculated and divided for circulating FDG, thus 
obtaining the arterial target-to-background ratio. Authors proved high reproducibility 
of this method and proposed it as a reference for PET vascular imaging, especially 
when PET is used to tracking changes in plaque inflammation over time and after 
therapy as a surrogate end point in clinical trials. 
The present analysis is in keeping with part of these recommendations (use of 
a PET/CT hybrid scanner, both mean and maximum SUV evaluation, and use of 
blood-pool activity for target uptake normalization). The lack of a so intensive 
evaluation might limit the reliability of the observation of normal glucose metabolism 
in the whole aorta. However, this limitation does not hamper the major finding of our 
study related to the low prevalence of visible FDG uptake in aneurysmal segment. 
As a collateral finding, the present study documented a slightly, though 
significantly, higher FDG concentration in the carotid arteries of patients with respect 
to control subjects. Obviously, this finding does not yet retain any diagnostic 
relevance because the small value of the observed difference implies a data overlap 
that will prevent a diagnostic conclusion in any single patient. However, from the 
pathophysiological point of view, it strongly supports the inflammatory nature of 
atherosclerosis that represents an important target for diagnostic methods aimed to 
estimate the risk for cardiovascular events. 
A limitation of this study was represented by relatively small aneurysm size 
(mean diameter of AAA was 5 cm) of patients. International guidelines suggest the 
surveillance with selective repair is generally most appropriate for older male patients 
with significant comorbidities. Good-risk patients aged <75 years and having a long 
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life expectancy with AAA between 5.0 and 5.4 cm may benefit from early repair  
(223). 
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6.8 Discussion 
 
 Objective 2 
The present study used an in vitro method to explain the low prevalence of 
positive findings at FDG PET imaging of asymptomatic AAAs with a size close to 
surgical indication. At this stage, diseased aortic walls typically display a marked 
reduction in cell density. Autoradiographic evaluation showed that radioactivity 
content was prevalently confined to populated islets being instead virtually absent in 
the residual, largely acellular, regions. The exposure to a transient thermal shock 
profoundly decreased cell tracer uptake, having only minor effect on the remaining 
acellular tissue. Altogether these data directly document that FDG retention 
accurately tracks glucose uptake being only modestly affected by unspecific binding. 
Accordingly, the extremely low FDG retention in these relatively large asymptomatic 
AAAs reflects the metabolic activity of an extremely low number of cells present 
within diseased arterial walls. 
The capability of PET to visualize FDG uptake in vulnerable atherosclerotic 
plaques (89, 224) or large vessel vasculitis (225) has already been documented. On 
the contrary, the clinical value of this tool in asymptomatic AAA patients is less clear, 
since the high prevalence of positive scans in preliminary studies has not been 
confirmed by more recent reports (218, 226). This variability agrees with the current 
model of AAA progression (34, 200) characterized by the repetitive sequence of 
inflammatory damage and repair. However, when arterial diameter reaches values 
close to surgical indications, cell density is eventually reduced throughout the 
aneurysmal walls (162 227-230). This sequence of events might thus imply a cyclic 
variation in FDG uptake in early stages and a progressive reduction of tracer 
retention in later ones. Accordingly, positive PET findings should be more frequently 
encountered in aneurysms of small size or in those involved in large inflammatory 
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processes that are more frequently associated with symptoms and require direct 
surgical repair (92). 
The micrometric analysis of FDG distribution and its coregistration with 
histology strongly corroborates this interpretation of the mechanisms underlying the 
reduced tracer retention in the diseased arterial segment. In fact, FDG uptake was 
extremely heterogeneous within the damaged arterial wall, with regions characterized 
by a “relatively preserved” metabolism clearly visible in the low background of the 
remaining vascular tissue. Metabolically inert areas were consistently located in 
fibrotic tissue, in endoluminal thrombus or in necrotic regions. These metabolic 
features agree with the pathological peculiarities of uncomplicated AAA characterized 
by the loss of smooth muscle cells and by the presence of infiltrating lymphocytes 
(227, 228) in contrast to the higher cell number and macrophage infiltration found in 
occlusive atherosclerosis (208) or in symptomatic AAAs complicated by inflammation 
(92). 
This concept is further corroborated by the coregistration of autoradiography 
with immunohistochemistry: FDG uptake closely correlated with the number of 
lymphocytes under active mitotic cycle as documented by Ki-67 staining (231). Thus, 
this in-depth analysis of tracer handling by aneurysmal walls indicates that FDG 
actually tracks the local glucose consumption. However, the overall number of cells 
entrapping this tracer is excessively low to permit the in vivo diagnosis of AAA 
inflammation, at least in these asymptomatic patients, whose arterial dilatation falls in 
a grey zone close to surgical indication. This clinical condition might thus be better 
approached by evaluating more specific molecular pathways. In this line, the high 
prevalence of lymphocytes in cellular infiltrates of diseased walls might represent the 
basis for imaging with tracer targeted to interleukin 2 (232). 
The technique of autoradiography is most often used to evaluate the 
distribution of tracers after their in vivo injection. However, under many experimental 
conditions, a direct incubation of biological samples is needed to verify the tissues 
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responsible for tracer uptake. In this setting, specimen physiology responds to an 
artificial environment in which signalling systems modulating cellular metabolism are 
lacking, oxygen tension is not preserved due to the absence of perfusion while tracer 
concentration remains relatively stable throughout the incubation period. Due to 
these considerations, this procedure does not permit testing of possible quantitative 
correlations between in vitro FDG uptake and in vivo SUV. On the contrary, it permits 
one to accurately verify the spatial distribution of the metabolic tracer within the 
analysed tissue. 
In vitro autoradiography can be performed according to two procedures: direct 
incubation of tissue sample and subsequent freezing for slice preparation (162, 230-
232) or preliminary freezing and sectioning followed by slice incubation (206, 233, 
234). The former protocol offers the advantage of a relatively preserved physiology of 
the experimental specimen. The latter procedure (206) permits exposure of all cells 
to the same tracer concentration, thus avoiding the possible presence of gradients 
between inner and outer layers that can occur in a freshly incubated sample. 
Although incubation of previously frozen slices improves the accuracy of receptor 
binding studies (233, 234), the exposure to a thermal shock profoundly disrupts 
cellular biology and viability hampering the link between FDG uptake and glucose 
metabolism. In this line, preliminary freezing can be considered as a tool to estimate 
the contribution of unspecific tracer binding to the overall FDG distribution in 
analysed tissue. Cell tracerbcontent eventually decreased to less than 15% in 
previously frozen slices with respect to values measured after incubation of the 
corresponding fresh specimen. On the contrary, preliminary freezing only modestly 
modified the radioactivity counts of necrotic and fibrotic regions. Thus, the selectivity 
of thermal shock effect documents that contamination from unspecific tracer binding 
plays a minor role in overall AAA FDG uptake. This finding extends previous 
observations reporting a high tracer uptake in acellular calcified regions in aortic 
specimens previously submitted to snap freezing (206). In this line, tracer uptake in 
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AAAwalls reflects both specific (metabolic) and unspecific binding mechanisms. The 
relative contribution of these two different pathways varies according to the stage of 
the lesion and thus to its cell density. 
Aortic dilatation remains most often asymptomatic throughout its progression 
until it reaches a size that requires intervention. This usually precludes obtaining 
fresh specimens of uncomplicated AAA in earlier disease stages. Therefore, we 
cannot extend the present observations to describe the natural history of AAA 
progression. Similarly, the present study does not elucidate the potential of PET/ CT 
imaging of FDG distribution in predicting aneurysm inflammation and risk of rupture 
in patients with aneurysms of relatively smaller size presenting with suspicious but 
non-diagnostic clinical features. 
However, the present study was planned to identify the biological 
mechanisms underlying FDG uptake in uncomplicated, asymptomatic AAA. In this 
line, the consistent nature of our findings, as well as their agreement with clinical  
studies in larger populations (226), permit us to explain the reason why 
asymptomatic patients with a relatively large aneurysm most often present an 
extremely low FDG uptake at PET imaging. 
In the present study, immunohistochemical evaluation of diseased aorta did 
not include CD68 staining to recognize macrophage infiltration. This selection was 
motivated by the evidence that the large majority of infiltrating cells (>80%) were 
lymphocytes. This finding agrees with the inclusion criteria that aimed to exclude 
patients with suspected AAA inflammation. In this line, the evidence of such a large 
lymphocyte presence in asymptomatic AAA suggests these cells play a role in the 
natural history of the disease, even in phases not characterized by active 
inflammation. 
Finally, the heterogeneous nature of cell populations in AAA specimens might 
partially reduce the agreement of data collected from different slices. This procedure 
was motivated by the fact that the short half-life of 18F implie an almost immediate 
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imaging of its distribution, while immunohistochemistry requires a long fixation time to 
obtain accurate image definition. To improve the accuracy of the coregistration 
procedure, great care was paid to ensure the contiguity of the slices submitted to 
autoradiography and immunohistochemistry. As a result, the correlation between 
tracer concentration and cell density was indeed robust enough as to document that 
FDG retention is modulated by its well-known determinants, i.e. local glucose uptake 
as an indirect index of cell density and metabolic activation. 
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6.9 Conclusion 
In conclusion, our results suggest that FDG uptake is most often very low and 
does not result in either hot spots or diffuse tracer retention in asymptomatic patients 
with AAA of diameter close to surgical indications. 
The possible accuracy of metabolic imaging in patients with relatively smaller AAA 
cannot be defined by the present data and remains an open question. 
AAA is the end result of a multifactorial process that is characterized by the 
progressive loss of cell populations associated with an irreversible remodelling of the 
arterial connective tissue eventually culminating in aortic rupture. These pathways 
are extremely complex and probably vary in the different disease stages. According 
to this concept, in AAAs whose size reaches a relatively large diameter, cell density 
is decreased to levels so low as to prevent any visible FDG uptake. 
The match between FDG behaviour and cell density confirms this concept 
and offers a good explanation of the extremely low prevalence of “positive” PET/CT 
scans in these patients. Obviously, this pathological picture is just one snapshot in 
time and may not be representative of all pathophysiological mechanisms underlying 
aortic rupture or progressive dilatation. These data therefore corroborate the concept 
that PET/CT imaging might not represent an accurate screening tool to identify 
rupture risk in these asymptomatic patients. In particular, the profound agreement 
between cell density and FDG uptake suggests that care should be taken in 
considering a negative PET scan as an index of low risk. As AAA diameter enlarges, 
in fact, the marked loss of cells and tissue structure within the diseased walls might 
increase the risk of rupture caused by mechanical stressors and amplified by aortic 
dilatation. 
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